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Abstract approve
Walt Ream
Agrobacterium tumefaciens is a gram-negative soil bacterium
that causes crown gall tumors on dicotyledenous plants. The
transferred DNA (T-DNA) portion of the A. tumefaciens tumor-
inducing (Ti) plasmid enters infected plant cells and integrates. into
plant nuclear DNA. The T-DNA is accompanied into plant cells by the
VirD2 endonuclease covalently attached to its 5' end. VirE2, a
cooperative, single-stranded DNA-binding protein is also
transported into plant cells during infection by A. tumefaciens.
VirD2 and VirE2 contain nuclear localization signals (NLSs) and are
transported into the plant cell nucleus.
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SINGLE-STRANDED DNA BINDING PROTEIN VIRE2
 
CHAPTER 1.  INTRODUCTION 
Overview of the Infection Process 
Agrobacterium tumefaciens causes crown gall disease on 
dicotyledenous plants (DeCleene and De Ley 1976; reviewed in Ream 
1989; Winans 1992; Hooykaas & Biejersbergen 1994). The A. 
tumefaciens-plant interactions are diagrammed in Figure 1.1.  A 
wounded plant secretes phenolic compounds, such as acetosyringone, 
which induce the virulence (vir) genes on the A. tumefaciens tumor-
inducing (Ti) plasmid. The vir genes and several chromosomally 
encoded virulence (chv) genes direct the transfer and integration of 
a region of the bacterial Ti plasmid into the plant genome.  This 
transferred DNA, known as the T-DNA, directs the overproduction of 
plant growth hormones which leads to the proliferation of infected 
cells,  resulting in crown gall tumor formation. 2 
phenolic
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secretion
 
wounded plant 
Vir 
T-DNA 
Ti plasmid  T- DNA  integration 
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Figure 1.1  Schematic diagram of the A.  tumefaciens-plant
interaction process that leads to tumor development. 
The open box represents the vir operons and the filled box the DNA 
that is transferred by A. tumefaciens to the plant cell nucleus and 
integrated into the plant genome. 3 
The transformed plant tissue produces novel compounds called 
opines.  Most opines are formed by the condensation of an amino acid 
with a keto acid or sugar (Dessaux et al. 1993). Opines are used as a 
nutrient source for A. tumefaciens and induce conjugal transfer of 
the Ti plasmid.  A. tumefaciens is a natural example of plant genetic 
engineering and is currently the most widely used method of plant 
transformation.  Agrobacterium transfers large segments (20 
kilobase or more) of DNA (Miranda et al. 1992) and protects the 
incoming DNA from rearrangements and duplications (Grevelding et 
al. 1993).  By more fully understanding the transfer process, this 
research may help to further increase the efficiency of plant 
transformation using A. tumefaciens and since VirE2 protein may 
play a role in T-DNA integration, an A. tumefaciens strain may be 
developed that can efficiently reintroduce isolated plant genes into 
their original location by homologous recombination.  In addition, 
this additional understanding of T-DNA transfer may suggest 
methods to prevent crown gall disease. 
A. tumefaciens strains are classified by the opines which they 
direct the host plant to synthesize.  A strain that directs the 
synthesis of an opine usually has corresponding opine catabolism 4 
genes located on its Ti plasmid.  However, many A. tumefaciens 
strains carry plasmids that are non-oncogenic but do have opine 
catabolism and opine-induced conjugal transfer loci (Kerr and Ellis 
1982).  Over twenty opines have been classified into mainly four 
families: octopine, nopaline, mannopine, and agrocinopine.  Opines 
belonging to other families exist and additional opines have been 
detected in tumors induced by at least three new classes of A. 
tumefaciens strains.  These opines are in the process of being 
characterized and classified (Dessaux et al. 1993).  An octopine-type 
Ti plasmid, pTiA6NC, directs the synthesis of octopine, agropine, and 
mannopine (Winans 1992).  A nopaline-type plasmid, pTiC58, directs 
the synthesis of nopaline and agrocinopines A and B (Winans 1992). 
The structural formulas of the opines secreted by plants infected by 
the nopaline- and octopine-type Ti plasmids are shown in Figure 1.2. 
Tumor-inducing  (Ti)  plasmid 
A genetic map of an octopine-type Ti plasmid is presented in 
Figure 1.3.  This Ti plasmid has two T-DNA regions that are 
transferred to the plant (TL T-DNA and Ts T-DNA). 5 
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Figure  1.2.  Structural formulas of representative opines. 
a) octopine b) agrocinopine A c) nopaline d) mannopine Synthesis  of 
octopine and mannopine are directed by pTiA6NC.  Synthesis of 
nopaline and agrocinopines A and B are directed by plasmid  pTiC58. 
(Winans 1992) 6 
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Figure 1.3.  Genetic map of an octopine-type Ti plasmid. 
(Ream 1989).  This plasmid has two T-DNA regions that are 
transferred to the plant, TL-TDNA and TR-TDNA.  This transfer is 
directed by the vir (virulence) genes.  This Ti plasmid also has tra 
and occ regions.  The opines synthesized by the infected plant induce 
conjugal transfer, directed by the tra genes and are catabolized by 
the occ genes. 7 
Nopaline Ti plasmids transfer a single T-DNA region.  The Ti plasmid 
also has opine catabolism and conjugal transfer regions. 
The vir genes on the tumor inducing (Ti) plasmid activate the 
T-DNA transfer process (Figure 1.3).  The vir gene products of 
octopine and nopaline strains are highly homologous (Rogowsky et al. 
1990).  VirA, an environmental sensor protein, phosphorylates VirG 
(Jin et al. 1990a).  Phosphorylated VirG binds to the vir boxes 
upstream of the vir operons to induce their transcription (Jin et al. 
1990b; Pazour and Das 1990). 
Together the VirD1 and VirD2 proteins form a site-specific 
endonuclease and nick the border repeats on either side of the T-DNA 
(Albright et al. 1987; Jayaswal et al. 1987; Stachel et al. 1986; 
Stachel et al. 1987; Veluthambi et al. 1987; Wang et al. 1987; 
Yanofsky et al. 1986).  This results in the release of a single-
stranded DNA molecule, known as the T-strand (Albright et al. 1987; 
Jayaswal et al. 1987; Stachel et al. 1986b). 
The VirB proteins and VirD4 form a membrane pore required for T-
strand export (Okamoto et al. 1991; Berger and Christie 1994; Ward 
et al. 1991; Zambryski 1992). 8 
VirE2, the single-stranded DNA binding protein, is also exported,
 
along with the T strand from A. tumefaciens (Often et al. 1984; 
Citovsky et al. 1992; Citovsky et al. 1994; Binns et al. 1995). 
Transferred DNA (T-DNA) 
One of the transferred DNA regions from an octopine type 
plasmid (TL T-DNA) is diagrammed in Figure 1.4.  There are 24-base 
pair (bp) border repeats on each end, and a sequence, overdrive, is 
adjacent to both right-hand border repeats (Peralta et al. 1986). 
This sequence is required for efficient transfer of both T-DNA 
regions from octopine-type strains (Peralta et al.  1986). 
The oncogenes, iaaM, iaaH, and ipt increase the production of 
the phytohormones, auxin and cytokinin (Schroder et al. 1984;  . 
Akiyoshi et al. 1984).  The genes for tryptophan monooxygenase 
(iaaM) and indoleacetamide hydrolase (iaaH) encode proteins that 
convert tryptophan to indoleacetic acid, an auxin (Inze et al. 1984). 
Isopentenyl transferase (ipt) catalyzes the last step in the 
biosynthesis of isopentenyl-AMP which is converted by the plant to 
trans-zeatin and trans-ribosyzeatin, both cytokinins (Akiyoshi et al. 
1984; Barry et al. 1984). 9 
T-strand 
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TL T-DNA 
mRNA 
Genetic 
Loots 
?  ?  iaaH  iaaM  ipt  ops  tml  ocs 
Function  Auxin Synthesis  Cytokinin  Opine  Octopine 
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Figure 1.4.  Genetic map of the TL T-DNA of an octopine­
type Ti plasmid.  The gene symbols indicate indoleacetamide 
hydrolase (iaaH), tryptophan monooxygenase (iaaM), isopentenyl 
transferase (ipt), opine secretion (ops), tumor morphology large 
(tm/), and octopine synthase (ocs) (Ream 1989). 10 
family (Kemp 1982).  The biosynthesis of a permease that allows 
opine secretion is directed by ops (Messens et al. 1985).  Mutations 
in tumor morphology (tml) typically result in larger than  normal-
sized tumors (Ream et al. 1983).  The other region transferred by 
octopine-type plasmids, TR T-DNA, directs the synthesis of two 
mannopine family opines, mannopine and agropine (Ellis et al. 1984). 
T-DNA Transfer 
T-DNA transfer requires the vir genes that lie on the Ti 
plasmid and some chromosomally encoded genes (reviewed in Ream 
1989; Winans 1992; Hooykaas and Bierjersbergen 1994). 
Initiation  of T-DNA Transfer:  VirA/VirG/ch v 
The initiation of T-DNA transfer depends upon A. tumefaciens 
sensing the plant wound environment.  Induction of the vir genes is 
influenced by phenolic compounds, sugar molecules, temperature and 
acidic pH.  The plant wound environment contains phenolics and 
monosaccharides as cell wall precursors (Reisert 1981) and tends to 
be acidic (Kahl 1982).  Phenolic compounds are absolutely required 11 
for induction to occur (Stachel et al. 1986a) and efficient induction 
by these compounds requires pH values between 5.2 and 5.8 (Stachel 
et al. 1986a).  Several sugars, including D-galacturonic acid and D­
glucuronic acid (both components of plant cell wall 
polysaccharides), glucose, arabinose, and galactose enhance 
induction when the concentration of the phenolic compounds is 
limited (Shimodo et al. 1990; Ankenbauer et al. 1990). 
The vir genes are transcribed at extremely low levels until 
induced by co-cultivation with plant cells or with phenolic 
compounds (Stachel et al. 1986a).  VirA and VirG are essential for a 
response to any of the environmental factors (Stachel and Zambryski 
1986) and they share similarities to other bacterial two-component 
regulatory proteins that detect environmental factors (Parkinson 
and Kofoid 1992).  VirA phosphorylates VirG, which increases its 
own transcription and that of the other vir operons (Powell et al. 
1988). 
VirA expression is increased five- to ten-fold by the phenolic 
compounds secreted by a wounded plant (Winans et al. 1988; 
Rogowsky et al. 1987).  The inner membrane spanning VirA protein 
has its C-terminus extending into the cytoplasm and its N-terminus 12 
into the periplasm (Melchers et al. 1989; Winans et al. 1989).  The 
periplasmic domain of VirA is similar in sequence to a domain in the 
Escherichia coli Tar protein (Melchers et al. 1989) which senses 
sugars and initiates chemotaxis toward them.  Due to the 
similarities in sequence between these domains, it was thought 
(Melchers et al. 1989) that the periplasmic domain of VirA 
interacted directly with acetosyringone.  However, the periplasmic 
domain of VirA was deleted without a loss of vir gene induction by 
acetosyringone (Melchers et al. 1989; Cangelosi et al. 1990; Shimoda 
et al. 1990).  In addition, two small cytoplasmic proteins bound an 
'I labeled analog of acetosyringone (Lee et al. 1992) which did not 
bind to VirA.  These chromosomally-encoded proteins may directly 
bind to acetosyringone, and then directly interact with VirA in a 
step prior to VirA/VirG vir gene induction.  Since mutations in this 
cytoplasmic domain of VirA eliminate vir gene induction by 
acetosyringone, this domain is thought to be involved in the 
interaction (Winans et al. 1994).  Recent genetic evidence suggests 
that VirA directly senses phenolic compounds (Lee et al. 1995).  Ti 
plasmids transferred into isogenic chromosomal backgrounds 
determined the response of the A. tumefaciens strain to individual 13 
phenolic compounds.  By subcloning the Ti plasmid, it was also 
determined that the differences in induction by the phenolic 
compounds are specifically linked to the virA gene (Lee et al. 1995). 
The authors of this paper (Lee et al. 1995) mention, in support of 
their evidence of VirA as the phenolic sensing protein, that neither 
of the two chromosomally-encoded proteins has been cloned.  This 
genetic evidence is a convincing argument that VirA is indeed the 
phenolic sensing protein. 
Although the periplasmic domain of VirA is not critical for 
induction by acetosyringone,  it  is crucial for the enhancement of 
induction by certain sugars (Shimoda et al. 1990).  This domain 
interacts with a periplasmic sugar binding protein, ChvE, that is 
chromosomally encoded (Cangelosi 1990).  ChvE is also required for 
the chemotaxis of A. tumefaciens towards certain sugars. 
A. tumefaciens causes tumors on plants only at temperatures 
below 32°C (Braun 1947).  The activity of VirA at elevated 
temperatures was investigated in an attempt to understand why A. 
tumefaciens does not infect plants at elevated temperatures.  Both 
the autophosphorylation of VirA and the subsequent transfer of this 
phosphate to VirG does not occur in vitro at temperatures above 32° 14 
C (Jin et al. 1993a), indicating that VirA might be responsible for
 
this temperature sensitivity.  Yet, a virG constitutive mutant strain, 
which activates transcription without VirA,  is incapable of 
infecting plants at temperatures above 32°C (Jin et al. 1993a). 
Consequently, other A. tumefaciens proteins may also be inactivated 
at higher temperatures, or the plant might become resistant to 
infection under these conditions. 
VirG has two domains, a DNA binding domain and a receiver 
domain (Winans et al. 1994). The C-terminal domain binds to the 
12-bp vir box sequences in vir gene promoters (Jin et al. 1990b; 
Pazour and Das 1990; Powell and Kado 1990) and the N-terminal 
domain is phosphorylated (Jin et al. 1990a; Roitsch et al. 1990). 
Three separate research groups have characterized a virG mutation 
that results in constitutive gene expression (Jin et al. 1993b; 
Sheeren-Groot et al. 1994; Han and Winans 1994).  This mutation 
(VirGN54D) changes an asparagine at position 54 to an aspartic acid, 
and the protein cannot be phosphorylated (Jin et al. 1993b) because 
it now has a negative charge near residue 52, the phosphorylation 
site.  Its constitutive phenotype mimics the activity of the wild-
type phosphorylated protein.  Both VirGN54D and phosphorylated 15 
wild-type VirG bind to a promoter containing two vir boxes with 10­
fold greater affinity than unphosphorylated VirG (Jin et al. 1993b). 
In a manner similar to other transcriptional activators (Aiba et al. 
1989), this increase in affinity to DNA may result from cooperative 
interactions between the phosphorylated receiver domains.  Both the 
wild-type phosphorylated protein and the mutant protein bind to DNA 
in a cooperative manner, supporting this conclusion. 
Since the discovery of chvE (Cangelosi et al. 1990), several 
other chromosomally-encoded virulence genes that influence 
induction have been reported (Mantis and Winans 1993; Charles and 
Nester 1993; Cooley et al. 1994; D'Souza-Ault et al. 1993; Gray et al. 
1993).  Another two-component regulatory system, similar to the 
VirANirG system has been identified and the genes have been 
sequenced (Mantis and Winans 1993; Charles and Nester 1993). 
Strains with mutations in either chvl (the target of phosphorylation) 
or chvG (a protein kinase) are avirulent and have low levels of vir 
gene expression.  Their precise functions are unknown.  Another 
chromosomal gene, ros, negatively regulates the virC and virD 
operons (Close et al. 1985; Cooley et al. 1994, D'Souza-Ault at al. 
1993) which are transcribed in opposite directions.  The VirG and 16 
Ros binding sites overlap each other in the common promoter region. 
After vir gene induction, VirG overcomes the repression of gene 
transcription by Ros.  Mutations in another chromosomal gene, miaA, 
which encodes t-RNA: isopentenyl transferase activity, decrease vir 
gene induction two- to ten-fold (Gray et al. 1992).  Without this 
tRNA modification enzyme, the translation efficiency of the vir 
genes is reduced. 
In summary, vir gene induction is a complex process that 
involves interactions between Ti plasmid and chromosomally-linked 
genes, and interactions between A. tumefaciens genes and plant 
signal molecules. 
T Strand  Creation: VirDlNirD2 
After induction of A. tumefaciens by acetosyringone, the 24-bp 
direct repeats flanking the T-DNA are nicked (Albright et al. 1987; 
Wang et al. 1987).  Border nicks are detected on the bottom strand 
between the third and fourth base pair in the border repeats of the 
octopine type Ti plasmid, pTiA6 (Albright et al. 1987).  The nicks 
occur within four hours after vir gene induction, and both VirD1 and 
VirD2 are required for border nicking in A. tumefaciens and E. coli 17 
(Jayaswal et al. 1987).  The action of this site-specific
 
endonuclease results in the release of a single-stranded DNA 
molecule, known as the T strand, which is subsequently transferred 
to the plant. 
The release of the T strand has been proposed to occur via DNA 
replication and strand displacement (Stachel et al. 1986b; Albright 
et al. 1987).  The nicked bottom strand of the right border provides 
the 3' OH group for initiation of replication, while the top strand 
provides a template.  Single-stranded DNA transfer also occurs in 
bacterial conjugation and its  similarities with T-DNA transfer will 
be discussed below.  Evidence for the transfer of single-stranded T-
strands to plant protoplasts has been presented (Yusibov et al. 
1994).  In these experiments, the bacteria attached to the 
protoplast cell walls were removed by centrifugation before DNA 
purification, and T-DNA was amplified using the polymerase chain 
reaction (PCR), from tobacco protoplasts within 30 minutes after 
co-cultivation with A. tumefaciens.  If the template DNA is treated 
with S1 nuclease, which is specific for single-stranded DNA, prior 
to the PCR, no PCR product was detected. To verify that the T 
strands were indeed from the protoplast cytoplasm and not from 18 
contaminating bacteria, several control experiments were performed 
(Yusibov et al. 1994).  No detectable PCR product was amplified from 
the bacteria attached to the protoplast cell walls and then removed 
by centrifugation or from uninfected plant cells extracted in a 
similar manner.  If the plant protoplasts were mixed with induced 
bacterial cells and the DNA from the protoplasts was immediately 
extracted, again no PCR products were observed.  Thus, the T-DNA 
molecules were associated only with infected plant protoplasts 
after co-cultivation with A. tumefaciens.  Using PCR primers 
directed against the Ti plasmid-encoded virA gene or an A. 
tumefaciens chromosomal gene, no PCR products were amplified 
from the infected protoplasts, confirming that bacterial cells did 
not contaminate the template DNA. 
VirD2 covalently attaches to the 5' terminus of the 
transferred single-stranded T strand molecule (Herrara-Estrella et 
al. 1988; Filichkin and Gelvin 1993; Ward and Barnes 1988; 
Durrenberger et al. 1986; Howard et al. 1989; Young and Nester 
1988)  Evidence for this bond was noticed during the isolation of T 
strand DNA from induced A. tumefaciens.  During phenol extraction, T 
strands are observed in the interphase between the aqueous and 19 
organic phases (Howard et al. 1989).  This suggests a DNA-protein 
interaction; this interaction is resistant to boiling in 2% SDS (an 
ionic detergent), indicating covalent bond formation. 
To demonstrate that this protein was VirD2, antisera to VirD2 
was used to immunoprecipitate DNA from acetosyringone-induced A. 
tumefaciens cells (Howard et al. 1989; Young and Nester 1988). 
Antisera against VirG did not precipitate any T-DNA molecules, 
whereas in a related experiment, a 58-kDa protein complexed with 
DNA was isolated from acetosyringone-induced A. tumefaciens cell 
extracts (Howard et al. 1989).  The DNA-protein complexes were 
treated with S1 nuclease, to digest single-stranded DNA, prior to 
analysis by SDS-polyacrylamide gel electrophoresis and 
immunoblotting.  Immunoblotting identified this protein as VirD2. 
In a site-directed mutagenesis experiment, each tyrosine 
residue in VirD2 was changed to a glycine to eliminate possible 
phosphodiester bond formation and determine the site of covalent 
DNA attachment (Vogel and Das 1992a).  Tyrosine 29 was found to be 
essential for endonuclease activity.  This amino acid participates in 
both border nicking and presumably in the formation of the covalent 
protein-DNA bond, since they are assumed to occur in a one-step 20 
process.  The nicked DNA from strains with mutations in each of the 
other tyrosine residues was covalently bound to protein, again 
suggesting tyrosine 29 participates in the DNA-protein complex 
formation. 
The activities of both VirD1 and VirD2, individually and 
together, have been characterized in vitro.  VirD1 protein may have 
type I topoisomerase activity as reported by Ghai and Das, 1989, and 
is able to convert supercoiled DNA to relaxed DNA by cleaving and 
rejoining the DNA, leading to unwinding.  However, other researchers 
have failed to detect this activity in purified VirD1 (Pansegrau et al. 
1993a). 
At this point,  it  is difficult to discard either observation.  The 
VirD1 protein was partially purified from E. coli by Ghai and Das 
using sucrose gradient centrifugation.  Although not completely 
purified, protein extracts from cells containing vector only and 
uninduced cells had no activity.  A positive control reaction using 
calf thymus topoisomerase I was also included.  Agarose gels clearly 
show additional DNA bands corresponding to relaxed DNA in the 
presence of the protein extract containing VirD1 protein and 
magnesium. 21 
The VirD1 protein purified by Pansegrau and his group 
(Scheiffele et al. 1995) was able to nick the T-DNA border sequence 
when combined with purified VirD2 protein.  However, it did not 
exhibit any DNA-relaxing activity.  This group as well, purified 
VirD1 from E. coli, and demonstrated that it  is an insoluble protein 
which must be solubilized in urea and renatured.  The lack of 
topoisomerase I  activity seen by the second group might be due to a 
difference in protein refolding during purification.  Because border 
nicking activity was observed when this purified VirD1 protein was 
in association with purified VirD2 (Scheiffele et al. 1995), at least 
part of the protein must have been correctly renatured. 
Purified VirD2 cleaves ssDNA (single-stranded DNA) containing 
a T-DNA border repeat sequence (Pansegrau et al. 1993a) at the same 
nucleotide sequence as observed in A. tumefaciens, and VirD2 also 
attaches to the 5' end of the cleaved oligonucleotide.  Purified VirD1 
and VirD2 catalyze the site- and strand-specific cleavage of dsDNA 
(double-stranded DNA) with a T-DNA border sequence (Scheiffele et 
al. 1995). The reaction requires Mg++ ions and supercoiled DNA.  Like 
the reaction of VirD2 with ssDNA, this reaction may also be an 
equilibrium reaction because when both proteins are in great molar
 22 
excess, only 35-40% of the substrate DNA is cleaved.  VirD1 either 
distorts the double-helix exposing the T-DNA border  sequence, or 
alters the specificity of VirD2 from single-stranded to double-
stranded DNA. 
Overexpression of VirD1 and VirD2 in A. tumefaciens by 
introduction of extra copies on a broad-host-range plasmid results 
in increased plant transformation efficiency (Wang et al. 1990). 
Tumor size on Kalanchoe daigremontiana and carrot increases and 
more tumors are found on potato discs.  Although the initial rate of 
T strand production is increased, the final T strand level inside A. 
tumefaciens is identical to a wild-type strain. 
The virD operon has two other open reading frames, virD3 and 
virD4. A fifth open reading frame, orf5, is downstream of virD4 and 
has its own promoter (Lin and Kado 1993).  Expression of orf5 is 
acetosyringone independent.  Since VirD4 is a membrane protein, its 
role in T-DNA transfer will be discussed with the VirB proteins. 
Neither virD3 nor orf5 are required for tumorigenicity  on plants 
(Vogel and Das 1992b; Lin and Kado 1993), and they will not be 
discussed further. 23 
Overdrive Binding Proteins: VirC
 
The exact functions of VirC1 and VirC2 proteins  are unknown. 
Evidence suggests VirC1 may bind to the overdrive  sequence during 
T-strand transfer (Toro et al. 1989).  Immediately adjacent to the 
right T-DNA borders in octopine-type Ti plasmids is  a conserved 
sequence designated overdrive that increases tumorigenicity 
(Peralta and Ream 1985; Peralta et al. 1986).  This sequence is fully 
functional on either side of the right border, in either orientation, 
and when located over 500 by away (Ji et al. 1988; van Haaren et al. 
1987).  Insertion mutations in virC1 or virC2 exhibit the same 
weakly virulent phenotype as an overdrive deletion strain (Ji et al. 
1988).  virC2 and overdrive double mutants exhibit this  same weakly 
virulent phenotype suggesting a possible interaction between the 
proteins of the virC operon and the overdrive sequence (Ji et al. 
1988).  VirC1 binds specifically to overdrive in a gel retardation 
assay (Toro et al. 1989) and in DNA affinity chromatography (Toro et 
al. 1989).  VirC2, however, is detected only in the flow-through from 
the overdrive DNA affinity column. 
VirC1 possibly also interacts with VirD2.  VirD2 protein is 
retained on DNA affinity columns with either the overdrive or right 24 
border sequences, suggesting a possible interaction between VirD2
 
and VirC1 and other A. tumefaciens proteins (Toro et al. 1989). 
VirC1 increases T-strand production in E. coli, but only when 
quantities of the VirD1/VirD2 endonuclease are limiting (DeVos and 
Zambryski 1989).  The role of virC in T-strand production in A. 
tumefaciens remains obscure.  Stachel et al. (1987) have reported 
virC mutations are unimportant in border nicking, while others 
notice only a slight decrease in border nicking (Toro et al. 1988). 
Membrane Pore Proteins: VirBNirD4 
The VirB proteins and VirD4 form a pore structure through 
which the T-DNA/protein complex is transported.  Eleven open 
reading frames are found in virB, the largest vir operon (Thompson 
et al. 1988).  VirB1, VirB2, VirB4, VirB5, VirB7, VirB8, and VirB9 all 
have cleavable signal sequences that allow transport across the 
inner membrane (Beijersbergen et al. 1994).  VirB2, VirB3, VirB6, 
VirB8 and VirB10 have hydrophobic domains also designating 
membrane localization (Beijersbergen et al. 1994).  Proteins without 
signal sequences can also be localized to bacterial membranes due 
to interactions with other proteins (Biejersbergen et al. 1994). 25 
Fusions between the virB genes and the gene coding for the 
enzyme alkaline phosphatase (phoA) which lacks its signal sequence 
have been used to determine VirB protein locations.  Alkaline 
phosphate activity is found only after the phosphatase part of a 
fusion protein is transported across the inner membrane into the 
periplasmic space (Manoil et al. 1990).  VirB proteins have also been 
localized to A. tumefaciens cell membranes using specific antiserum 
to individual VirB proteins.  By this method, induced A. tumefaciens 
cells are fractionated into cellular components and immunoblots of 
these fractions determine the locations of the proteins.  Using 
sequence analysis, alkaline phosphatase fusions and immunoblots, 
all of the VirB proteins have been localized to one or both A. 
tumefaciens cell membranes (Fernandez et al. 1996a, Thorstenson et 
al. 1993; Shirasu and Kado 1993; Beijersbergen et al. 1994). 
VirB1 was localized to either the inner membrane, or to both 
the inner and the outer membranes, depending upon the fractionation 
method applied (Thorstenson et al. 1993).  VirB2 was localized to 
both the inner and outer membranes (Shirasu and Kado 1993). The 
majority of VirB3 was localized to the outer membrane (Shirasu and 
Kado 1993).  VirB4 localized to the inner membrane (Shirasu et al. 26 
1994; Thorstenson et al. 1993) or to both membranes (Thorstenson 
et al. 1993), again depending upon the fractionation method used. 
Since VirB4 lacks a hydrophobic domain, its localization  may be due 
to interactions with other VirB proteins (Beijersbergen et al.  1994). 
An active phoA fusion with VirB5, indicates  a periplasmic location 
(Beijersbergen et al. 1994).  Using immunoblots, VirB5 has been 
localized to both the inner membrane and soluble fractions 
(containing cytoplasm and periplasm) (Thorstenson et al. 1993). 
VirB6 has five strongly hydrophobic domains and phoA fusion 
of this protein was active (Beijersbergen et al. 1994), leading  to the 
prediction that it  is an inner membrane protein with five 
transmembrane loops.  VirB7 has its amino terminus anchored 
predominantly to the outer membrane and its carboxy domain in the 
periplasmic space (Fernandez et al. 1996a).  VirB8 and VirB9 have 
been localized to both the inner and outer membranes using 
immunoblot analysis (Thorstenson et al. 1993, Shirasu and Kado 
1993).  However, VirB8 has also been localized solely to the inner 
membrane using VirB8 antisera and immunogold labeling of thin 
sections of A. tumefaciens (Thorstenson and Zambryski 1994). 
VirB10 and VirB11 have been localized to the inner membrane (Ward 27 
et al 1990; Christie et al. 1989; Thorstenson et al. 1993) or to both
 
the inner and outer membranes, depending upon the fractionation 
method used (Thorstenson et al. 1993). 
VirB4 and VirB11 have nucleotide binding sites and ATPase 
activity (Shirasu and Kado 1993; Ward et al. 1990), and may provide 
energy for T-DNA transport.  VirB4 must be able to bind ATP to 
function in T-DNA transfer (Fullner et al. 1994).  VirB11 belongs to a 
protein family of nucleotide binding proteins required for secretion 
in gram-negative bacteria (Pugs ley 1993) and mutations in VirB11 
that abolish its nucleotide binding site result in an avirulent 
phenotype (Stephens et al. 1995). 
VirD4, an essential virulence protein, was detected in the 
inner membrane fraction and in fractions that sedimented between 
the inner and outer membrane fractions, as determined by 
immunoblot analysis and sucrose density gradient centrifugation 
(Okamoto et al. 1991). The N-terminus of VirD4 has a signal 
sequence, and active PhoA fusions were constructed using the N-
terminal region of VirD4.  Therefore, the C-terminal region of VirD4 
is most likely located in the periplasm, while the N-terminal region 
anchors VirD4 to the inner membrane. 28 
All of the VirB proteins, except VirB1, are required for
 
virulence (Berger and Christie 1994).  Since the VirB proteins and 
VirD4 are not involved in T strand formation and  are essential for 
virulence, their membrane localization suggests they  are essential 
for T-DNA export.  VirB9, VirB10 and VirB11 are tightly associated 
with the cell membranes and may form a protein complex spanning 
the inner and outer membranes (Finberg et al. 1995).  VirB10 exists 
in A. tumefaciens as a membrane-associated protein complex (Ward 
et al. 1990), as treatment of A. tumefaciens whole cells or 
membranes with protein crosslinking reagents results in the 
formation of higher molecular weight forms of this protein.  VirB10 
either associates with itself or with other membrane proteins. 
Recent work indicates VirB7 interacts with and stabilizes the 
putative T-complex transport apparatus (Fernandez et al. 1996b). 
Without VirB7, the steady-state levels of VirB4, VirB9, VirB10 and 
VirB11 are reduced.  Trans expression of VirB7 partially restored 
the levels of these proteins and trans expression of VirB7 and VirB8 
fully restored the levels of these proteins to wild-type (Fernandez 
et al. 1996b). Therefore, genetic evidence implicates that VirB4, 29 
VirB7, VirB8, VirB9, VirB10 and VirB11  are involved in the 
formation of the putative T-complex transport  apparatus. 
VirE1/VirE2 
The virE operon encodes two proteins, VirE1 (65 amino  acids) and 
VirE2 (533 amino acids) (Winans et al. 1987), and both are needed 
for tumorigenesis (McBride and Knauf 1988). In the A.  tumefaciens 
cell, VirE2 is primarily located in the cytoplasm, although  it  is also 
found in the inner and outer membranes and in the periplasm 
(Christie et al. 1988).  A third open reading frame further 
downstream may be important for virulence  on some hosts (tomato) 
but not on others (K. daigremontiana) (McBride and Knauf 1988). 
VirE2 binds cooperatively and without  sequence specificity to 
single-stranded DNA (Gietl et al. 1987; Das 1988; Christie  et al. 
1988; Citovsky et al. 1988; Citovsky et al. 1989; Sen  et al. 1989), 
but does not bind to dsDNA or ssRNA (Sen et al. 1989).  In 
cooperative binding, the binding of one molecule of VirE2 facilitates 
the binding of other VirE2 molecules through  a protein/protein 
interaction between adjacent VirE2 molecules.  Cooperative ssDNA 
binding is supported by gel retardation experiments that give a sharp 30 
transition from free to fully retarded ssDNA probe with increasing 
VirE2 concentration (Citovsky  et al.  1989).  Electron microscopy of 
ssDNA with subsaturating amounts of VirE2 protein demonstrated 
molecules either coated completely with VirE2 or protein-free, also 
indicating cooperative binding (Sen  et al.  1989).  VirE2 has been 
reported to convert collapsed ssDNA into extended structures 
(Citovsky  et al. 1989; Sen  et al.  1989) or to increase the diameter of 
the ssDNA (Sen  et al.  1989). Two electron micrographs in the Sen 
paper clearly show the increase in diameter of the ssDNA due to 
binding of the VirE2 protein, the VirE2 protein coated ssDNA strands 
are more than twice as thick as the dsDNA. Therefore, VirE2 must 
increase the diameter of the ssDNA. 
VirE2 has traditionally been assigned a protective role in T­
DNA transfer (Citovsky  et al.  1989; Sen  et al.  1989; Christie  et al. 
1988).  Because VirE2 is a ssDNA binding protein, it is assumed to 
coat the T strand and protect it from nucleases inside the A. 
tumefaciens cell and during its transfer into the plant cell.  In vitro, 
VirE2 protects ssDNA from degradation by the nuclease, DNase I (Sen 
et al.  1989).  VirE2-specific antiserum immunoprecipitates T-DNA 31 
from the supernatant of induced A. tumefaciens cells (Christie et al. 
1988), although these complexes might form after cell lysis. 
In contrast to this view, evidence is accumulating that VirE2 
is exported directly into, and functions within, plant cells.  First, 
VirE2 is not required to protect T strands from nucleases inside A. 
tumefaciens, as they accumulate to normal levels in a virE mutant 
strain (Stachel et al. 1987, Veluthambi et al. 1988).  In addition, 
VirE2 is necessary only inside the plant cells as determined by  a 
VirE2-producing transgenic tobacco plant that forms tumors when 
inoculated with a virE2 mutant A. tumefaciens strain (Citovsky et al. 
1992). 
VirE2 is exported separately from T-DNA into plant cells 
during extracellular complementation.  In this assay, two A. 
tumefaciens strains, a virE2 mutant and a virE+ strain lacking the T­
DNA region, when co-inoculated onto a plant, subsequently formed 
tumors (Otten et al. 1984).  Each strain alone is avirulent and unable 
to exchange genes by conjugation.  The virE strain requires virA and 
virG for vir gene induction and the membrane proteins of the virB 
operon and virD4 for VirE2 export ( Otten et al. 1984).  Tight binding 
to plant cells is required of both strains (Christie et al. 1988, 32 
Dombek and Ream, unpublished data), suggesting the direct export of 
VirE2 into plant cells rather than into the virE2 mutant A. 
tumefaciens strain.  An alternative explanation is that the T-strands 
are exported into the VirE2-producing A. tumefaciens strain and then 
into plant cells.  However, PCR failed to amplify T-strands from A. 
tumefaciens cells that were co-cultivated with tobacco protoplasts 
(Yusibov et al. 1994) suggesting that T-strands are only transferred 
from A. tumefaciens directly into plant cells. 
VirE1 is also required for the export of VirE2 in the 
extracellular complementation assay (Sundberg et al. 1996), 
suggesting an interaction between VirE1 and VirE2.  Another 
observation supports this interaction:  although VirE2 is stable in A. 
tumefaciens without VirE1 (Sundberg et al. 1996), VirE2 is not 
stable in E. coli without VirE1 (McBride and Knauf 1988; P. Dombek 
and W. Ream unpublished data).  In contrast, T-DNA can be exported 
from the virEl deletion strain in the extracellular complementation 
assay (Sundberg et al. 1996), an example of T-DNA export 
independent of VirE2 protein. 
The broad-host-range plasmid RSF1010 can be exported by A. 
tumefaciens into plant cells (Buchanan-Wollaston et al. 1987).  This 33 
plasmid prevents tumorigenesis by sequestering VirB proteins
 
required for T-DNA export (Ward et al. 1991).  Coordinate 
overexpression of virB9, -10, and -11 restored tumorigenesis of this 
A. tumefaciens strain. In the extracellular complementation  assay, 
RSF1010 prevents transfer of VirE2 into plant cells, however it does 
not block the movement of uncoated T strands from a virE2 mutant 
into plant cells (Binns et al. 1995).  Binns cites this evidence to 
suggest the direct export of VirE2 into plant cells (Binns et al. 
1995).  Apparently, the RSF1010 intermediate competes with VirE2 
for VirB proteins in the transport pore.  Nonpolar mutations in virB 
genes 4, 5, 6, 8, 9, or 10 eliminate export to plant cells of both 
VirE2 and T strands in this assay (Binns et al. 1995).  Thus, both 
uncoated T-strands and VirE2 are exported through a common 
transport apparatus and both interact directly with the VirB 
proteins.  The possible functions of VirE2 inside the plant cell will 
be discussed in the section on T-DNA integration. 34 
Similarities Between T-DNA Transfer and Bacterial 
Conjugation 
T-DNA transfer from A. tumefaciens to plant cells is a process 
that mimics bacterial conjugation, and this relationship was first 
noted by Stachel and Zambryski (1986).  The broad host-range 
plasmid RSF1010 can be transferred into plant cells by A. 
tumefaciens (Buchanan-Wollaston et al. 1987).  Bacterial 
conjugation is a process that involves cell-to-cell contact and 
single-stranded DNA transfer (Brock et al. 1994).  During 
conjugation, the DNA transferred may be a plasmid or part of the 
chromosome mobilized by a plasmid.  The conjugative plasmid in the 
donor cell codes for surface structures and proteins required for 
DNA transfer.  The surface structures are called sex pili and they 
make contact between the donor and recipient cells and recognize 
receptors on the recipient cell surface.  After initial contact, the 
pili  retract and the cells are pulled together, facilitating 
transmembrane pore formation. 
Membrane fusion may occur between the donor and recipient 
cells.  After contact, the conjugal plasmid DNA is nicked in the donor 
cell and one parental strand is transferred to the recipient.  As the 35 
transfer occurs, the donor cell replaces the transferred strand by 
rolling circle method of DNA replication.  A complementary DNA 
strand to the transferred strand is likewise synthesized in the 
recipient, and when conjugation is concluded, both donor and 
recipient cells possess the complete plasmid. 
VirD1/VirD2:  Similarities  to  TraJ/Tral 
VirD1 and VirD2 share functional similarities with the TraJ 
and Tral proteins encoded by the plasmid RP4 (Pansegrau and Lanka 
1991; Lessl and Lanka 1994; Kado 1994).  RP4 is a conjugative 
broad-host-range plasmid (IncP) that can be transferred to gram-
positive and gram-negative bacteria, and also to yeast (Lessl and 
Lanka 1994).  Tral and TraJ form a nucleoprotein complex with the 
origin of transfer (oriT) of RP4 (Pansegrau and Lanka 1991).  Both 
Tral and TraJ are required in vitro for site- and strand-specific 
cleavage of oriT (Pansegrau et al. 1994).  Correspondingly, both 
VirD1 and VirD2 are required in vitro for specific cleavage of the T­
DNA borders (Scheiffele et al. 1995). 
During conjugation, TraJ binds to oriT and loads Tral onto the 
DNA.  Similar in size to TraJ, VirD1 may also load VirD2 onto DNA in 36 
an analogous reaction (Lessl and Lanka 1994).  As mentioned 
previously, the function of VirD1  is unclear; one group found that 
purified VirD1 has topoisomerase activity (Ghai and Das 1988), 
while another group did not (Scheiffele et al. 1995). 
There are remarkable similarities between Tral and VirD2. 
Purified Tral catalyzes a site-specific cleavage and joining reaction 
on ssDNA containing the nic region of oriT, and covalently attaches 
via its tyrosine 22 to the 5' terminus of the nicked DNA (Pansegrau 
et al. 1993b).  VirD2 also catalyzes a cleaving and joining reaction 
on ssDNA containing a border repeat sequence (Pansegrau et al. 
1993a) and attaches via tyrosine 29 to the 5' end of the transferred 
DNA (Vogel and Das 1992a).  The amino acid sequence of VirD2 
shares a relaxase motif with Tral and proteins from other 
mobilizable plasmids (Pansegrau and Lanka 1991).  Consensus nick 
sequences have been found between the T-DNA border repeat 
sequences and the RP4 transfer origin (Waters et al. 1993). 
Interestingly, VirD2 can also nick ssDNA containing the nic sequence 
from RP4, whereas, Tral cannot nick the border repeat sequence 
(Pansegrau et al. 1993b).  VirD1 may increase the specificity of 
VirD2 in vivo (Pansegrau et al. 1993a). 37 
VirBNirD4 Pore: Similarities to Conjugal Pore and 
Pi lin  Production  Proteins 
It  is not clear whether A.  tumefaciens forms a pilus-like 
structure, although homologies exist between the VirB proteins and 
proteins involved in pilus structure and assembly.  In addition to 
TraJ and Tral, other RP4 proteins share similarities in amino  acid 
sequence and genetic organization to Vir proteins.  The plasmid RP4 
has two regions that direct conjugative transfer, tral and tra2 
(Less) et al. 1993).  tra2 and one protein encoded by tral are 
required for pilus formation, as determined by electron microscopy. 
Six of these tra2-encoded proteins share between 39% and 53% 
conserved amino acid sequence to corresponding VirB proteins (Less) 
et al. 1993) and this similarity extends to gene organization.  Most 
of the Tra2 proteins are also hydrophobic and have N-terminal signal 
sequences. The amino acid sequences of TrbE and TrbB, tra2 
proteins, share 48% and 52% similarity to the amino acid sequences 
of VirB4 and VirB11 respectively (Less) et al. 1993; Less! and Lanka 
1994).  All four proteins have consensus nucleotide binding sites.  In 
addition, both VirB11 and TrbB possess ATPase and 38 
autophosphorylation activity (Lessl et al. 1993).  VirB4 also 
hydrolyzes ATP (Shirasu et al. 1994). 
Both VirB2 and the tra2-encoded TrbC have sequence 
similarities to the pilus subunit (TraA) of E. coli  F plasmid (Shirasu 
and Kado 1993; Kado 1994).  VirB2 and TraA have peptidase signal 
cleavage sites and both are cleaved to generate proteins of 7.2 kDa 
(Shirasu et al. 1990). The 7.2 kDa TraA protein is the pilin 
structural protein (Frost et al. 1984).  The F plasmid also requires 
TraQ and TraX for TraA processing (Maneewannakul et al. 1993). 
Analogous VirB proteins have not been found (Kado 1994). 
Four VirB proteins (in addition to VirB2) are similar to 
proteins encoded by the F plasmid (Kado 1994). These F plasmid 
proteins are essential for its conjugal transfer.  TraL and VirB3 
share 42% amino acid similarity while TraC and VirB4 share 46% 
amino acid similarity.  Both TraL and TraC are required for pilus 
formation and are thought to be involved in pilus assembly (Kado 
1994). 
In addition, more VirB proteins share amino acid  sequence 
similarities to proteins encoded by the trw operon of the IncW 
broad-host-range plasmid R388 than to any other operon (Kado 39 
1994). Ten of the eleven VirB proteins share between 42% to 59% 
amino acid sequence similarity to proteins encoded by this  operon, 
which encodes pilin assembly and subunit proteins. 
The proteins encoded by the trb operon of RP4, the trW operon 
of R388, the tra operon of F, and the virB operon are similar in amino 
acid sequence and genetic organization to the ptl operon of 
Bordetella pertussis.  This bacterial pathogen causes the respiratory 
disease whooping cough and it secretes a multi-subunit complex 
known as pertussis toxin.  Thus, the VirB protein transmembrane 
structure could have broad specificity and secrete both proteins and 
DNA (Kado 1994). 
VirD4 shares conserved amino acids with proteins found in the 
plasmids RP4 and F. Comparing VirD4 and TraG of RP4, 28% of the 
amino acids are identical (Kado 1994). TraG also has a signal 
sequence for transport to the inner membrane and is essential for 
conjugal transfer.  Although TraG is not involved in pilus formation, 
it is thought to be part of a membrane channel.  TraD, essential for F 
plasmid transfer, shares 43% amino acid similarity to VirD4 
(Okamoto et al. 1991). 40 
Recently, a cluster of conjugal transfer genes from the IncN 
plasmid, pKM101, that direct the synthesis of the pilus and mating 
pore was sequenced (Pohlman et al. 1994). Using phoA gene fusions, 
11 of the 18 conjugal transfer proteins were found to be exported 
from the cytoplasm.  tra genes with amino acid similarities to 
virB1, -2, -3, -6, -8, -9 and -11 were found, and the operons were 
similarly arranged.  Amino acid sequence similarities were also 
found between the tra operon of pKM101 and the ptl operon (Pohlman 
et al 1994). 
VirE2:  Similarities  to TraC1 
VirE2, like the TraC1 primase of RP4 is a non-specific ssDNA 
binding protein.  This primase activity initiates DNA replication in 
the recipient cell, converting the transferred single-stranded DNA to 
double-stranded DNA.  TraC1 is transported with the transferred 
single-stranded DNA into recipient cells and protects  it from 
nuclease attack.  However, TraC1 and VirE2 do not share any regions 
of conserved amino acid sequence and VirE2 lacks the primase 
activity of TraC1 (Schieffele et al.  1995). 41 
RSF1010 Transfer by  A.  tumefaciens 
As previously mentioned, the broad host-range plasmid 
RSF1010 can be transferred into plant cells by A. tumefaciens 
(Buchanan-Wollaston et al. 1987).  Transfer is dependent upon the 
mob genes and the origin of transfer (oriT) of RSF1010 (Buchanan-
Wollaston et al. 1987). The Mob proteins nick the DNA at oriT and 
transfer is dependent upon A. tumefaciens Vir proteins encoded by 
the virA, virG, virB and virD operons, while mutations in virC or virE 
reduce transfer efficiency (Buchanan-Wollaston et al. 1988). 
Integration of the T-DNA into the Plant Cell Nuclear DNA 
VirD2/VirE2:  Nuclear Localization Signals 
Inside the plant cell, the T-DNA must be targeted 
into the plant cell nucleus before integration can occur. Both VirD2 
and VirE2 contain short stretches of basic amino acids that act as 
nuclear localization signals (Shurvinton et al. 1992; Tin land et al. 
1992; Howard et al. 1992; Citovsky et al. 1992; Citovsky et al. 
1994). 42 
VirD2 has two functional domains, an N-terminal domain for T
 
strand attachment and border nicking and a C-terminal nuclear 
localization signal (Shurvinton et al. 1992; Tin land et al. 1992).  The 
VirD2 nuclear localization signal is important for tumorigenesis but 
not for T strand production (Shurvinton et al. 1992). The nuclear 
localization signal transports the reporter enzymes 0-glucuronidase 
(GUS) and 13-galactosidase to the nucleus of both yeast and tobacco 
cells (Tin land et al. 1992; Howard et al. 1992).  The VirD2 nuclear 
localization sequence functions in both monocots and dicots.  A 
VirD2- 13-glucuronidase fusion protein accumulates in the nuclei of 
maize leaves and immature maize roots (Citovsky et al. 1994). 
VirE2 has two nuclear localization signals that function in 
plants.  Either signal, when fused to 0-glucuronidase, directs  it  into 
tobacco cell nuclei (Citovsky et al. 1992).  However, in the monocot 
maize, only the nuclear localization sequence closest to the N-
terminus is functional.  VirE2 without this sequence no longer 
transports 0-glucuronidase into the nuclei of maize leaves and 
immature maize roots (Citovsky et al. 1994). 
In the plant, VirD2 directs the T-strands into the nucleus 
(Tin land et al. 1995).  If tobacco seedlings are infected by a virD2 43 
mutant A.  tumefaciens strain without its nuclear localization
 
signal, only 5% of the T-DNA molecules enter the nucleus compared 
to infection by a wild-type A.  tumefaciens strain (Tin land et al. 
1995).  In this assay, transient gene expression was measured by 
inserting the reporter gene (uidA) that codes for 13-glucuronidase 
into the T-DNA, and this construct allowed the transient expression 
of the reporter gene to be measured shortly after infection by A. 
tumefaciens.  Three days after infection, the seedlings  were 
incubated in the p-glucuronidase substrate, X-gluc, and transient 
expression was measured by counting the number of blue spots that 
appear on each seedling. The uidA gene does not necessarily have to 
be integrated to be transiently expressed.  However, it must be 
converted to double-stranded form and transcribed. 
Illegitimate  Recombination 
Sequence analysis of T-DNA insertions and their respective 
plant DNA target sites have revealed several commonalties 
(Bakkeren et al. 1989; Ohba et al. 1995; Mayerhofer et al. 1991; 
Gheysen et al. 1991). However, no consensus sequence has been 
found that predicts the site of T-DNA integration.  The T-DNA 44 
sequence at the left (3') end of the integrated T strand is more
 
variable than the right (5') end.  For example, in six of eight 
transformed tobacco plants the right T-DNA end  was conserved 
(Tin land et al. 1995).  In contrast, fifteen of eighteen transformants 
had deletions of up to 52 nucleotides from their 3' ends (Rossi  et al. 
1996; Gheysen et al. 1991; Mayerhofer et al. 1991).  Larger 
truncations, up to 181 nucleotides, have also been observed (Ohba et 
al. 1995). 
Frequently, short sequences (1-7 bp) of homology  are found 
between the T-DNA ends and the pre-insertion sites (Gheysen et al. 
1991; Mayerhofer et al. 1991; Ohba et al. 1995)  In most cases, 
additional nucleotides ("filler" DNA) corresponding to duplications 
of both plant and T-DNA occur at the junction sites (Gheysen et al. 
1991; Mayerhofer et al. 1991; Ohba et al. 1995).  Short target site 
deletions (13-73 bp) occur in most cases, although larger target 
rearrangements have also been observed (Gheysen et al. 1991; 
Mayerhofer et al. 1991; Ohba et al. 1995). 
T-DNA integration occurs by illegitimate recombination 
(Gheysen et al. 1991; Mayerhofer et al. 1991; Ohba et al. 1995), 
which is also involved in the integration of viral and transfected 45 
DNA into mammalian cells (for review see Roth and Wilson 1988). 
T-DNA integration and illegitimate recombination in mammalian 
cells share several commonalities: the absence of well-defined 
target sites (only short regions of homology are required), the 
presence of additional nucleotides at the recombinant junctions, and 
small deletions or larger rearrangements at the target sites 
(Gheysen et al. 1991).  Only 1-6 by of homology are required 
between the single-stranded ends of the virus SV40 and the target 
site of integration in monkey cells (Roth and Wilson 1986). When 
SV40 integrates into mammalian chromosomes, about 10% of the 
junctions contain from 1-40 additional nucleotides of filler DNA at 
the recombinant junctions (Roth et al. 1989).  In contrast, 
approximately 40%, of T-DNA junctions contain filler DNA, of up to 
40 nucleotides (Gheysen et al. 1991).  In one example, an 11-bp 
deletion of the target site occurred upon integration of hepatitis B 
virus DNA cloned from hepatocellular carcinomas and a region of 5 
by homology was found between the cellular DNA deleted at the 
target site and the integrated hepatitis B virus DNA (Hino et al. 
1989). 46 
Illegitimate recombination in A. tumefaciens involves T-DNA 
joining to the free ends of nicked plant DNA (Gheysen et al. 1991). 
Nicks in DNA can occur due to errors during replication or repair, or 
when ssDNA is exposed during transcription (Roth and Wilson, 1988). 
T-DNA integrates preferentially  into transcriptionally active 
regions of the plant genome (Koncz et al. 1989). 
Role of VirD2 in T-DNA Integration 
The in vivo participation of VirD2 in the integration event is 
supported.  In a recent paper, an A. tumefaciens strain with a virD2 
mutation was used to infect tobacco seedlings (Tin land et al. 1995). 
After infection, the integration efficiency of this strain was 
compared to a wild-type strain and integrated T-DNA molecules 
were recovered from the infected plants and sequenced.  The 
sequences obtained were compared to T-DNA sequences integrated 
due to infection by a wild-type A. tumefaciens strain. 
VirD2 has a motif common to many recombinases (His-(2X)-
Arg-(32+/-2X)-Tyr) (Argos et al. 1986).  The arginine of this motif 
was changed to a glycine (virD2R129G) to disrupt a possible 
integration function and this construct was used to infect tobacco 47 
plants.  The level of T strands produced by this strain was less than 
1% of the wild-type level, probably due to a conformational defect in 
the VirD2 protein. 
The integration efficiency of this virD2R129G mutant strain 
was first compared to a wild-type strain (Tin land et al. 1995).  The 
integration efficiency was determined by measuring the frequency 
of T strands integrated into the plant cell nucleus and dividing this 
number by the frequency of T strands transported into the plant cell 
nucleus, but not necessarily integrated.  For each strain, the 
integration frequency of the T strands was determined by counting 
the number of calli that arose on tobacco seedlings after A. 
tumefaciens infection and selection on media containing kanamycin. 
T strand transport to the nucleus was determined by measuring the 
transient expression of a 0-glucuronidase reporter gene as the 
number of blue spots that appeared on tobacco seedlings three days 
after A. tumefaciens infection.  Using these methods, the integration 
efficiency was found to be unaffected by this virD2 mutation 
(Tin land et al. 1995). 
Although the integration efficiency was reported to be 
unchanged, changes were noticed when the T-DNA from plants 48 
transformed by this strain was sequenced (Tin land et al. 1995). The
 
precise ligation of the T-DNA right border to the plant DNA did  not 
occur in any of the eight transformed plants (Tin land et al. 1995).  In 
six of the eight plants transformed with a wild-type strain,  the 
right border junction was intact.  In four of the plants transformed 
with the virD2 mutant, multimers of the complete plasmid  were 
found, suggesting a mechanism of rolling circle replication during T­
DNA transfer.  This indicates that VirD2 participates in the ligation 
of the T-DNA to the plant DNA and is required for the precise 
integration of the right T-DNA border into the plant DNA (Tin land et 
al. 1995). 
If VirD2 does participate in the ligation step,  as postulated by 
Tin land et al. (1995) it appears unlikely that the integration 
efficiency is not decreased using the virD2R129G mutant strain.  The 
efficiency of both T-DNA transfer to the plant cell nucleus 
(measured by blue spots per seedling) and T-DNA integration 
(measured by calli formed per seedling) was decreased in the 
virD2R129G mutant strain to approximately equal  a 1:250 dilution of 
a wild-type strain with a completely avirulent A.  tumefaciens 
strain (Tin land et al. 1995).  This A. tumefaciens strain, with a 49 
deletion in virD2, is avirulent, as T-DNA border nicking and T  strand 
formation do not occur.  Therefore, approximately 250-fold fewer T 
strands are transferred into the plant cell nucleus by the 
virD2R129G mutant strain compared to a wild-type strain. 
The integration efficiencies were determined for 1:100,  1:250 
and 1:500 dilutions of a wild-type strain mixed with the virD2 
deletion strain and compared with the integration efficiency of  the 
undiluted virD2R129G mutant strain (Tin land et al. 1995). The 
integration efficiencies obtained for the three dilutions of the wild-
type strain in three separate experiments were 0.14 +/- 0.03, 0.032 
+/- 0.006, 0.07 +/-0.008 (mean +/- standard deviation).  The three 
experiments have over a 4-fold variation in integration efficiency 
(from 0.032 to 0.14) casting doubt on the ability of this procedure  to 
accurately determine integration efficiency.  For the virD2R 129G 
strain the integration efficiencies obtained in the three experiments 
were 0.108, 0.013 and 0.087 respectively (Tinland et al. 1995). 
Wide variability (over 7-fold from 0.013 to 0.108) is again  seen in 
these experiments.  The virD2R129G mutation had a slightly lower 
integration efficiency in the first two experiments and  a slightly 
higher integration efficiency in the third experiment.  In all three 50 
cases the value for the virD2R129G strain was outside  the standard 
deviation of the mean value found using the  diluted wild-type strain 
(Tin land et al. 1995)  Therefore, it appears unconvincing on the 
basis of three widely differing experiments  to conclude that the 
virD2R129G strain does not change the efficiency  of T-DNA 
integration.  Another more consistent method needs to be  developed 
or more than three separate experiments need to be performed. 
Role of VirE2 in T-DNA Integration 
To assess the influence of virE2 on T-DNA integration in 
plants, a virE2 deletion strain was used to infect tobacco seedlings 
(Rossi et al. 1996).  This experiment was executed by the  same group 
that infected the tobacco seedlings with the virD2  mutant (Tin land 
et al. 1995) using an identical procedure to the one described in the 
preceding section.  The efficiency of integration  was also found to 
be virE2 independent. 
It appears likely that VirE2, like VirD2, does change  the 
integration efficiency.  In the next section, evidence will be 
presented implicating VirE2 protein in T-DNA integration.  The 
efficiency of T-DNA transfer from A. tumefaciens  to the plant cell 51 
nucleus (measured by blue spots  per seedling) matches a 1:2500 to 
1:5000 dilution of a wild-type strain diluted  with a strain 
containing a deletion in virD2 (Rossi et al. 1996).  The number of 
blue spots that appeared per seedling after inoculation with the 
virE2 deletion strain was fewer than 1  per seedling.  In one of the 
three experiments performed, the number of calli  formed after 
inoculation with the virE2 deletion strain  was less than 1 per 100 
seedlings (Rossi et al. 1996).  Therefore, in the integration 
efficiency experiments with the virE2 deletion strain the limit of 
accurately detectable T-DNA transfer and integration  events may 
have been exceeded. This might have also been the case using the 
virD2R129G mutant strain which  was 250-fold less efficient than 
wild-type in T-DNA transfer (Tin land et al. 1995). 
In three independent experiments using 1:500,  1:1000 and 
1:5000 dilutions of a wild-type strain, with the virD2  deletion 
strain, the integration efficiencies were 0.045 +/- 0.01,  0.040 +/­
0.005, 0.34 +/- 0.21 (Rossi et al. 1996).  A large variation, over 8­
fold from 0.04 to 0.34, is again seen in the transfer  efficiencies 
obtained in the three experiments.  The integration efficiencies of 
the virE2 deletion strain were 0.028, 0.092, and 0.5,  respectively 52 
(Rossi et al. 1996).  The first value, and the second value are lower
 
and higher respectively, than the mean values determined for the 
wild-type strain in the first two experiments.  The third value is 
within the mean value plus the standard deviation of the wild-type 
strain.  Therefore, as with VirD2, the results seem inconclusive due 
to the large variation in the integration efficiency values obtained. 
Sequence analysis of the T-DNAs integrated after infection 
with the virE2 deletion strain were compared to T-DNAs obtained 
after infection with a wild-type strain (Rossi et al.  1996).  Twenty-
one transgenic plants infected with the virE2 mutant A. tumefaciens 
strain were regenerated and their T-DNAs analyzed.  Seventeen of 
the plants had precise T-DNA/right border junctions.  A similar 
percentage of plants infected with a wild-type strain also had this 
precise junction.  VirE2, therefore, does not influence the 
integration pattern of the 5' end of the T-DNA. As previously 
discussed, VirD2 protein is needed for a precise 5' junction. 
However, when the left-end junctions were analyzed, only four 
of the twenty-one plants had deletions of fewer than 52 bp, and 
were therefore similar to the left-end junctions found in the four 
plants transformed with a wild-type strain (Rossi et al. 1996). The 53 
remaining seventeen plants transformed with  the virE2 mutant had 
left-end truncations of up to 1  kb.  Plants with larger deletions  may 
have been present but were not selected because truncations greater 
than 1430 by also deleted part of the kanamycin  resistance gene and 
therefore would not be detected. 
The authors propose that VirE2 protects ssDNA  from nucleases 
inside the plant cell and, therefore, is needed for integration of full-
length copies of T-DNA (Rossi et al. 1996).  Without virE2, the 
transfer efficiency of the T-DNA into the plant cell  nucleus, as 
determined by the transient expression  assay, was only 0.02-0.04% 
of wild-type (Rossi et al. 1996).  The quantity of T strands formed 
inside the virE2 mutant was identical to that observed  in a wild-
type strain (Rossi et al. 1996), which supports previous  reports 
(Stachel et al. 1987; Veluthambi et al. 1988).  Therefore, these left 
hand truncations may have occurred inside the plant cell. The 
transient expression of the reporter gene encoding  13-glucuronidase 
in seedlings infected with a virE2 mutant strain  was lower (Rossi et 
al. 1996), as expected, because fewer T-DNA molecules are detected 
in the cytoplasm of protoplasts co-cultivated with  a VirE2 mutant 
as compared to wild-type (Yusibov et al. 1994). 54 
T-DNA degradation inside the plant cell due to a lack of VirE2 
is also supported by the following observation:  when tobacco 
seedlings were infected by co-inoculating the virE2  deletion strain 
with a virE÷ strain, the integrated T-DNAs in four  of the five plants 
had left end T-DNA truncations of less than 52  by and were 
therefore similar to plants infected by wild-type A.  tumefaciens 
(Rossi et al. 1996).  Therefore, VirE2 can be exported from A. 
tumefaciens and still protect the T strand from degradation. 
The authors state that the A. tumefaciens proteins  VirD2 and 
VirE2 are responsible for the transport and precise  integration of 
full-length T-DNA copies (Rossi et al. 1996).  The sequencing results 
support this conclusion, since without a fully-functional  VirD2 
protein, the 5' end of the integrated T-DNA molecule  is truncated 
and without VirE2, the 3' end is truncated  more extensively (up to 1 
kb) than it would ordinarily be (less than 52 bp). 
It has been suggested that VirE2  may also participate in T-DNA 
integration (Gardner and Knauf 1986) in addition  to protecting the T­
DNA from nucleases inside the plant cell (Rossi et al.  1996).  In a 
unique experiment, plant viroid genes were inserted into the T-DNA 
(Gardner and Knauf 1986).  Mutations in the vir genes were made to 55 
assess their effect on viroid and T-DNA transfer.  Mutations in the 
virB or virD operons prevented tumor formation  and viroid 
symptoms.  Mutations in virE2 resulted in viroid symptoms but  no 
tumors (Gardner and Knauf 1986).  This indicates that the T-DNA 
entered the plant nuclei but did not integrate.  The authors suggested 
VirE2 is involved in T-DNA integration.  However, since viroid 
symptoms are a sensitive assay of T-DNA transfer,  an alternative 
explanation (that fewer T strands  were transferred and therefore 
integration did not occur) is also possible. 
Genetic evidence has shown that VirE2 can mediate 
homologous genetic recombination in E. coli (W. Ream  unpublished 
data).  This experiment utilized an E. coli strain containing  two 
copies of the lac operon in its bacterial chromosome  and a deletion 
of the region including recA. The copies of the lac operon had non-
overlapping deletions in lacZ, the gene encoding the enzyme 8­
galactosidase, and its activity was used to  screen for recombination 
events.  Only when a complete copy of lacZ is created, by homologous 
recombination,  is 0-galactosidase activity present.  A plasmid 
containing the virE operon under control of the IPTG-inducible 56 
promoter,  trc, was introduced into this E. coli strain to determine  if 
VirE2 could substitute for RecA. 
RecA is the major recombination protein of E.  coli, which like 
VirE2, binds cooperatively and without  sequence specificity to 
ssDNA.  In homologous recombination, RecA binds ssDNA and,  without 
regard to sequence homology, binds dsDNA in  a second binding site 
(Roca and Cox 1990).  This process is known as co-aggregation. 
RecA then searches for homologous regions between the  ss and 
dsDNA.  If homology is found, RecA displaces  one of the strands of 
dsDNA and replaces it with homologous ssDNA in the strand exchange 
process (Roca and Cox 1990). 
In the recombination experiments, E. coli cells  were grown 
overnight in the presence of IPTG to induce the virE  genes and plated 
on lactose minimal medium containing X-gal.  E. coil cells with a 
functional copy of lacZ will be able to utilize lactose and grow on 
the lactose minimal plates.  X-gal is a substrate for 0­
galactosidase, and is converted to a blue-colored compound in its 
presence. When virE was present, blue colonies arose on the lactose 
minimal plates.  No colonies grew using the same E. coli strain 57 
containing the vector alone or containing virE with a truncated virEl 
gene. 
PCR (polymerase chain reaction) primers  were designed so that 
only when they were brought into close proximity to one another by a 
recombination event would a product be obtained. The  DNA from 
several blue colonies resulting from VirE2-mediated  recombination 
was amplified using these primers, and products of the expected 
sizes were generated.  Sequencing revealed the wild-type lacZ 
sequence, verifying that VirE2 can mediate genetic recombination in 
E. coll. 
Some differences were observed between recombination 
mediated by VirE2 and that mediated by RecA. The frequency of 
recombination was much less in the virE-containing  strain, with 106 
fewer colonies generated, and the virE-mediated  recombinants were 
also unstable.  If a blue colony arising from virE mediated 
recombination was grown in broth and re-plated  on lactose minimal 
medium, only a fraction of the cells survived.  The virE-mediated 
recombination intermediates were not properly resolved in  E. coil. 
VirE2 has an identical site-specific recombinase  motif 
(His229-2X-Arg226-32+/-2X-Tyr192) to one found in VirD2.  Site­58 
specific recombination, unlike homologous  recombination, requires 
only very short regions of homologous DNA. This motif  (Argos et al. 
1986) is found in a family of conservative  site-specific 
recombination proteins encoded by seven different  bacteriophage 
systems:  X, 080, P22, P2, 186, P4, and P1 (reviewed by  Nash 1981). 
Each system has a different site-specificity, which  might account 
for the large diversity seen in the overall protein  sequences (Argos 
et al. 1986). 
In the first six systems, recombination  occurs between 
specific att sites on the phage and bacterial chromosomes.  This 
event is carried out by the phage-encoded integrase (Int)  protein 
(Nash 1981; Yu and Haggard-Ljungquist 1993; Pierson and Kahn 
1984).  In the P1 system, P1 is maintained  as a bacterial plasmid 
and Cre protein resolves dimer copies of this plasmid  into daughter 
cells during bacterial replication (Austin et al. 1981).  Flp is a 
eukaryotic protein similar to Cre, that also shares this  motif 
(McLeod et al. 1984).  This yeast protein is involved in recombination 
between copies of the 211 plasmid. 
In vitro, the recombinase proteins Cre, Flp, and X  integrase 
generate staggered nicks in the DNA (Craig and Nash 1983; Andrews 59 
et al. 1985; Hoess and Abremski 1985).  There is no evidence that 
VirE2 nicks DNA. VirD2 may generate the nicks in the plant DNA or 
the T-DNA may preferentially integrate into nicked DNA.  Cre, Flp, 
and X integrase then attach transiently to the 3' end of the DNA via a 
phosphodiester bond during strand cleavage and rejoining (Craig  and 
Nash 1983; Andrews et al. 1985; Hoess and Abremski 1985).  This 
bond energy is conserved during strand exchange,  as no high energy 
co-factor is  required. 
VirD2, VirE2 and Flp lack the less-highly conserved amino 
acids that surround this integrase motif and are shared by some of 
the bacteriophage proteins (P. Dombek unpublished data).  VirE2, 
however, does have a Thr471-Gly470-X-Arg468  motif that occurs about 
100 amino acids away from the integrase motif in five of the 
bacteriophage proteins.  Roles for all three amino acids in the 
integrase motif have been proposed (Argos et al. 1986). The 
histidine hydrogen bonds with specific DNA sequences, the arginine 
ionically interacts with the DNA phosphate backbone, and the 
tyrosine forms a transient phosphodiester linkage with the DNA. 
To determine whether this motif in virE2 is important in T­
DNA integration, site-directed mutagenesis could be used to change
 60 
inactivate a possible recombination function,  as it would be 
expected to eliminate transient phosphodiester bond  formation 
between the protein and DNA. The mutant VirE2 protein  should 
retain the ability to bind ssDNA, as this motif is in  the N-terminal 
half of the protein.  The ability of this mutant VirE2 protein  to 
mediate genetic recombination in E. coil and infect  plants could also 
be tested to determine the significance of this motif. 
VirE2 could also be purified and tested for both  strand 
exchange and co-aggregation activities.  VirE2, like RecA during  co­
aggregation, may bind to dsDNA in the presence of both ssDNA and 
magnesium. 
Research Objectives 
At 533 amino acids in length, VirE2 protein is larger than E. 
coli RecA (353 amino acids) (Cox and Lehman 1987), E.  coli SSB (178 
amino acids) (Chase and Williams 1986), and bacteriophage T4 (301 
amino acids) (Alberts and Frey 1970).  All three proteins bind 
cooperatively and non-specifically to ssDNA (Alberts and Frey  1970; 
Chase and Williams 1986; Cox and Heiman 1987). Both  RecA (Cox and 
Lehman 1987; Gardner et al. 1995) and gp32 (Casas-Finet et al. 61 
1992; Hurley et al. 1993) are multi-functional proteins  and it  is 
likely VirE2 may also have several functional domains.  VirE2 has 
one or more domains involved in binding ssDNA and since this binding 
to ssDNA is cooperative, it also has one or more cooperativity 
domains.  VirE2 participates in other protein-protein  interactions 
since its export from A. tumefaciens requires six of the  virB 
proteins, as well as VirD4 and VirE1 (Binns et al. 1995;  Often et al. 
1984; Sundberg et al. 1996).  Therefore, a domain or domains that 
interact with these other vir proteins is expected.  Since VirE2 can 
also mediate genetic recombination, a region of VirE2  may 
participate in T-DNA integration. 
Therefore, the main objective of this research  was to identify 
the domains required for ssDNA binding and cooperativity. 
Additionally, this research may identify other domains that  did not 
affect ssDNA binding but are important for other functions of  the 
VirE2 protein. 
The approach taken utilized linker-insertion mutagenesis (Goff 
and Prasad 1991) to add two amino acids throughout the protein,  to 
minimize the probability that the mutations would introduce  large 
three-dimensional conformational changes that would destabilize 62 
the protein and lead to a total loss of activity.  These insertions 
were intended to perturb only a portion of the protein, which could 
indicate its function.  Additionally, a ten amino acid deletion  was 
created in a serine-rich region of VirE2 that shares 66% amino  acid 
identity with a region in gp32 (P. Dombek unpublished data).  This 
region in gp32 is surrounded by acidic amino acids and  participates 
in protein-protein interactions with other proteins that  participate 
in bacteriophage T4 replication (Hurley et al. 1993; Krassa  et al. 
1991).  Therefore, it was hoped this deletion could eliminate the 
interaction of VirE2 with one or more other A. tumefaciens  proteins 
or plant proteins. 
E. coli protein extracts containing the wild-type and  mutant 
VirE2 proteins were used to determine their ssDNA binding  abilities 
in electrophoretic mobility shift assays.  Immunoblot analysis was 
used to determine the amount of VirE2 protein in each extract, and 
the binding to ssDNA was quantitated using a phosphorimager.  This 
approach allowed for the detection of small differences in the DNA 
binding abilities between the wild-type and mutant VirE2 proteins. 
Virulence assays were also performed using A. tumefaciens 
strains containing the wild-type and mutant VirE2 proteins  to 63 
correlate changes in DNA binding with changes  in phenotype.  VirE2 
is a plant-host-range determining protein  by using transposon 
mutagenesis to construct truncated versions of VirE2 (Hirooka and 
Kado 1986).  Consequently, plants from several families  were 
infected. 
The results of this research demonstrated  that the C-terminal 
half of VirE2 contains a domain critical for ssDNA binding; two 
insertions in the N-terminal half identified  cooperativity domains. 
An insertion in the central region of VirE2  decreased tumorigenicity 
but did not affect ssDNA binding or the stability of VirE2 in A. 
tumefaciens.  This mutation might define another functional  domain. 
Surprisingly, the 10 amino acid deletion did not  change ssDNA 
binding or virulence.  Chou and Fasman (1978) secondary  structural 
predictions of the linker insertion mutants suggested  only localized 
changes in the secondary structure of VirE2 due  to these insertions. 
Consequently, linker insertion mutagenesis is  a potential method for 
determining protein functional domains. 64 
CHAPTER 2.  EXPERIMENTAL PROCEDURES
 
Bacterial  Strains, Plasmids, and Growth Conditions 
Listed in Table 2.1 are the bacterial strains  and plasmids used 
in this study.  All A. tumefaciens strains were derived from  A348, 
which harbors the octopine-type Ti plasmid pTiA6NC  in the C58 
chromosomal background (Garfinkel et al. 1981).  Escherichia coli 
cells (MM294, DH5a, SK1592) were grown in L-broth  (Maniatis et al. 
1982) containing appropriate antibiotics at 37°C.  A. tumefaciens 
cells were grown in YEP (Garfinkel et al. 1981) containing 
appropriate antibiotics at 28°C. 
Construction of virE2 Mutants 
Linker Insertion  Mutagenesis 
The linker inserted into virE2 in pGR1  was the 12-bp 
oligonucleotide 5'-dCTCGAGCTCGAG-3') which contains two Xhol 
sites (one of which is underlined). 65 
Table 2.1  Bacterial Strains and Plasmids 
Strain or plasmid  Characteristics  Reference 
E. coli 
DH5oc  F- recA1 gyrA96 thi-1 hsdR17  Clontech 
supE44 re/Al deoR 
480dlacZAM15 A,­
A(lacZYA-argF)U169 
CJ236  dut-1 ung-1 thi-1  Joyce and 
relA //pCJ 105(F' cat)  Gridley 
1984 
JC10,289  F- del(srl- recA)306::Tn 10 thr-1  Csonka and 
leuB6 thi-1 lacY1 galK2 ara-14  Clark 
xyl-15 proA2 his-4 argE3 rpsL31  1979 
tsx-33 supE44 mtl-1 
MM294  F- endA1 thi-1 hsdR17 supE44  Bachmann 
1987 
A. tumefaciens 
A348  C58 chromosomal background  Garfinkel 
containing pTiA6NC  et al. 
1981 
WR5000  2.4 kb Hindi fragment containing  This study 
neo from Tn5 replacing virE2 in 
pTiA6NC 
WR5100  pPD100 transformed into WR5000:  This study 
virE1+ virE2+/virE::neo 66 
WR5101­
WR5108 
pPD101-pPD108 transformed into 
WR5000 
This study 
WR5110  pPD110 transformed into WR5000  This study 
Plasmids 
pBL17  pTrc99A with only one Sphl site  This study 
pGR1  3.2 kb Xhol fragment containing 
virE from pTiA6NC inserted into 
Sall site of pUC18 
Sundberg 
et al. 
1996 
pPD1  Xhol linker inserted into Stul site 
30 by from virE2 start in pGR1 
This study 
pPD2  Xhol linker inserted into Xmnl site 
281 by from virE2 start in pGR1 
This study 
pPD3  Xhol linker inserted into Rsal site 
638 by from virE2 start in pGR1 
This study 
pPD4  Xhol linker inserted into Nael site 
768 by from virE2 start in pGR1 
This study 
pPD5  Xhol linker inserted into Nrul site 
1133 by from virE2 start in pGR1 
This study 
pPD6  Xhol linker inserted into Rsal site 
1414 by from virE2 start in pGR1 
This study 
pPD7  Xhol linker inserted into Pvull site 
1489 by from virE2 start in pGR1 
This study 
pPD8  Xhol linker inserted into Nael site 
1526 by from virE2 start in pGR1 
This study 
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pPD10  codons 56-65 of virE2 deleted 
from pGR1 
This study 
pPD15  2.4 kb Hindi fragment containing 
neo from Tn5 replacing virE2 
in pGR1 
This study 
pPD16  BamH1-cut pPD15 inserted into 
BamH1 site of pRK310 
This study 
pPD20  1.9 kb EcoR1 fragment from pGR1 
inserted into the EcoR1 site of 
pUC118 
This study 
pPD25  codons 56-65 of virE2 deleted in 
pPD20 
This study 
pPD100  BamH1-cut pGR1 inserted into 
BamH1 site of pRK310 
This study 
PPD101-108  BamH1-cut pPD1-pPD8 inserted 
into BamH1 site of pRK310 
This study 
pPD110  BamH1-cut pPD10 inserted 
into BamH1 site of pRK310 
This study 
pPD201-208  Sphl fragments containing virE2 
from pPD1-pPD8 in  Sphl  site 
of pWR223 
This study 
pPD210  Sphl fragment containing virE2 
from pPD10 in  Sphl  site 
of pWR223 
This study 
pRK310  broad-host-range  tetA  lacZ' 
pUC9 multiple cloning site 
Ditta 
et al. 
1985 
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pTrc99A 
pWR223 
pW R225 
trcP vector  laclq pUC18 EcoRI­
Hind111 polylinker region 
annealed Ncol/Sphl oligonucleo­
tides containing the first 10 codons 
of virEl (through Sphl site) with 
Ncol and Sphl compatible ends 
inserted into Ncol-Sphl-cut pBL17 
(Fig. 3.6) 
Sphl fragment containing the virE 
operon from the Sphl site in virEl 
through the end of virE2 (from pGR1) 
in Sphl site of pWR223 
Amann 
et al. 
1988 
Pharmacia 
This study 
This study 
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This linker was designed so that it would not change the 
reading frame or add a stop codon when inserted into virE2. The 
plasmid pGR1 was first linearized with one of the following blunt-
cutting restriction enzymes; Nael, Rsal, Stul, Pvull, Xmnl which cut 
throughout virE2 and within the vector.  The resulting linearized DNA 
was then gel purified and ligated to the oligonucleotide linkers. 
Restriction endonuclease reactions contained 5-10 jig pGR1 plasmid 
DNA, 8.8 III 10X restriction enzyme buffer (0.5 M Tris-HCI (pH 8.0), 
100 mM MgCl2), 2 RI RNase (5 mg/ml stock), plus dH2O to 88 IA total 
volume. Two µl ethidium bromide (1 mg/ml stock) was then added to 
maximize the number of DNA molecules that would be cut only once 
(Goff and Prasad 1991).  Twenty units of the blunt-cutting 
restriction enzyme of choice was then added to the digest.  The 
reaction was incubated at 37°C for 70 minutes, followed by 
inactivation of the enzyme by heating to 65°C for 10 minutes.  The 
digested DNA was subjected to electrophoresis through an 1% 
agarose gel using pGR1 (linearized with BamHl) as a marker for the 
migration of full-length linear molecules.  The linearized DNA was 
purified from agarose as described in the DNA methods section 70 
(section 2.3).  The purified DNA was then concentrated by ethanol 
precipitation and resuspended in 20 IA water. 
The 5' ends of the oligonucleotide linkers (1.7 i.tg linker DNA) 
were phosphorylated in 30 ill of buffer consisting of 0.1M Tris-HCI 
(pH 8.0), 10 mM MgCl2, 5 mM dithiothreitol, and 0.43 mM ATP. One IA 
(10 units) T4 polynucleotide kinase (Bethesda Research 
Laboratories) was then added and the reaction was incubated at 37°C 
for 45 minutes.  The phosphorylated linkers were then ligated to the 
gel-purified linearized DNA by adding 1  jig DNA to 1.7 1.1g 
oligonucleotide linkers, 17 ill 5X T4 DNA ligase buffer (330 mM Tris-
HCI (pH 7.6), 33 mM MgCl2, 50 mM dithiothreitol, 330 mM ATP) 
(Bethesda Research Laboratories), 4 p.1 (4 units) T4 DNA ligase 
(Bethesda Research Laboratories), and dH2O to bring the total volume 
of the reaction mix to 85 gl.  The reaction was incubated overnight 
at 15°C. 
To ensure that only a single Xhol site was inserted into the 
ligated DNA, the ligation reaction was digested with Xhol, which 
cleaves within the 12 by linker sequence.  The DNA in the ligation 
mix was extracted with an equal volume of phenol/chloroform (1:1) 
and then extracted again with an equal volume of 71 
chloroform/isoamyl alcohol (24:1).  The DNA was then ethanol 
precipitated, resuspended in 27 j.il  of 1 X restriction enzyme buffer 
(50 mM Tris-HCI (pH 7.4), 10 mM Mg C12, 50 mM NaCl) and 3 ill Xhol 
(30 units), then incubated at 37°C for one hour.  This typically 
resulted in the insertion of just 6 by (two codons, CTCGAG) 
indicating complete Xhol digestion. 
Excess linkers were separated from the linearized DNA by 
electrophoresis through a t% Sea Plaque low-melting temperature 
agarose gel (FMC Bioproducts) which resolved two bands; an upper 
band of linearized DNA and a diffuse lower band of linker DNA. The 
linearized DNA band was excised and ligated without purification 
from the agarose as follows.  The DNA-containing agarose, 
containing about 0.7 lig DNA, was first melted at 70°C.  Using 10 III 
of molten agarose, 4 IA 5X ligation buffer (330 mM Tris -HCI (pH 7.6), 
33 mM MgCl2, 50 mM dithiothreitol, 330 mM ATP), 4.5 RI water, and 
1.5 pi T4 DNA ligase (1.5 units), the DNA was re-ligated overnight at 
room temperature. The ligation reaction was heated to 70°C and 10 
ill used to transform 200 RI competent cells (described in section 
2.3 on DNA methods). 72 
The resultant E. coli colonies were screened  to determine the
 
site of the linker insertion.  Miniprep DNA was isolated and digested 
with Xhol and BamHl. BamHl cuts once in the multiple cloning site of 
pGR1, approximately 300 by upstream from the  start of virEl, and 
Xhol cuts only at the site of the mutation. To  show that other 
alterations did not occur during linker insertion,  the Central 
Services Laboratory (Oregon State University)  sequenced each 
mutation with an Applied Biosystems Model 373  sequencer using the 
dye-terminator method. 
Site-directed  Mutagenesis 
To prepare single-stranded template DNA, the  DNA fragment to 
be mutagenized was cloned into pUC118 which has an M13 origin of 
replication.  The virE containing plasmid, pGR1  was cut with EcoRl 
and the 1967 by EcoRl fragment containing both virEl  and the N-
terminal half of virE2 was ligated into pUC118, previously 
linearized with EcoRl. The resulting plasmid, pPD20,  was 
transformed into E. coli strain CJ236 (chloramphenicol  resistant) 
and plated on L agar plates containing both ampicillin (50  µg /ml) and 
chloramphenicol (30 µg/m1).  The cells were grown overnight in L 73 
Broth plus antibiotics, and 25 p,I of this culture was used to
 
inoculate 2 ml of L Broth supplemented with  0.001% thiamine. 
Ampicillin (25 µg/m1) was added and the culture  was incubated at 
37°C with shaking for 30 minutes.  Forty gl of M13K07 helper phage 
(at a concentration of 0.5-5 x 10'1 pfu/ml) was added to the culture 
which was then incubated for an additional  two hours at 37°C with 
shaking. The entire culture was added to 8 ml of L Broth 
supplemented with 0.001% thiamine, 25  µg /ml ampicillin, and 50 
µg /ml kanamycin.  Kanamycin selected for cells infected by the 
helper phage. 
Cells were shaken for 16 hours at 37°C and  the bacterial 
debris was pelleted by centrifugation at 12,100  x g for 10 minutes. 
Three ml of 2.5 M NaC1/20°/0 PEG was added to 9 ml of the phage 
supernatant and the solution was placed at 4°C overnight.  The 
solution was centrifuged in an SS34 rotor at 12,100 x g for 10 
minutes which resulted in a beige-colored, round pellet of phage 
particles containing single-stranded pPD20 DNA. The  supernatant 
was removed from the pellet as completely as possible. 
The pellet was resuspended in 0.5 ml of TE and 2 gl RNaseA (5 
mg/ml) was added. The DNA was incubated at 37°C for 20 minutes 74 
and then was extracted twice with phenol/chloroform  and extracted
 
once with chloroform/isoamyl alcohol.  Each extraction was re-
extracted by adding 200 gl of TE to the leftover  phenol/chloroform 
or chloroform/isoamyl alcohol which doubled the yield of  DNA. The 
DNA was ethanol precipitated, washed in 75% ethanol, allowed to 
air-dry and resuspended in 100 g.I of TE. One gl of  the single-
stranded DNA was analyzed by electrophoresis  through an 0.8% 
agarose gel, with supercoiled double-stranded DNA as a control.  A 
single band of single-stranded DNA  was visible at a lower position 
than the supercoiled plasmid DNA. The single-stranded  DNA 
concentration was determined by measuring the OD260. 
Prior to synthesis of second strand DNA,  an oligonucleotide 
primer (200 pmol) was phosphorylated in 30 gl of buffer consisting 
of 0.1 M Tris-HCI (pH 8.0), 10 mM MgCl2, 5 mM  dithiothreitol, and 
0.43 mM ATP. To delete codons 55-66 from virE2,  an 
oligonucleotide primer corresponding to codons 50-54  and 65-69 in 
virE2 was designed and synthesized (5'-GGA-TCG-GTC-GAT-TCC­
GGA-AAT-CAA-GCT-GAG-3').  This primer contains a BspEl site 
(underlined) which is not found in virE or pUC118.  Five units of T4 
polynucleotide kinase (Bethesda Research Laboratories) were added 75 
and the solution was incubated at 37°C for 45 minutes and then 
incubated at 65°C for 10 minutes to inactivate the enzyme.  Three ill 
of TE were added to bring the oligonucleotide to a final 
concentration of 6 pmol /µl.  The phosphorylated primer was stored 
frozen. 
The phosphorylated primer was then annealed to the single-
stranded DNA template. One lig of template DNA, 1  ill of 
phosphorylated oligonucleotide primer (6 pmol), 2 gl of 5X Sequenase 
buffer (200 mM Tris-HCI (pH 7.5), 100 mM MgCl2, 250 mM NaCI) 
(United States Biochemical), and 6 ill of dH2O were added to a 
microfuge tube.  An identical reaction was set up without the 
oligonucleotide primer and with 7 ill of dH2O instead of 6 IA  Both 
reactions were placed in a beaker of H2O at 70°C and the water was 
allowed to cool to 30-35°C. To each of the 10 1.t.1  annealing reactions 
(with and without the oligonucleotide primer) 20 pi of buffer 
consisting of 20 mM Tris-HCI (pH 7.5), 10 mM MgCl2, 25 mM NaCI, 75 
mM APT, 5 mM dithiothreitol, 100 mM dATP, 100 mM dTTP, 100 mM 
dCTP, 100 mM dGTP, 1.6 units of Version 2.0 Sequenase DNA 
polymerase (United States Biochemical), and 0.33 units of T4 DNA 
ligase (Bethesda Research Laboratories) were added on ice.  The 76 
reactions were incubated at room temperature for 5 minutes and 
then incubated at 37°C for 75 minutes to complete the  synthesis of 
second strands. 
Two p.I of each reaction was analyzed by  agarose gel 
electrophoresis with single-stranded template DNA  and supercoiled 
plasmid DNA as controls.  In the control reaction without the 
oligonucleotide primer, little DNA corresponding to the  double-
stranded supercoiled plasmid was visible, whereas in the  reaction 
with the oligonucleotide added, considerably  more DNA 
corresponding to the double-stranded plasmid DNA  was observed. 
Two gl of each reaction was used to transform E. coll. Three  times 
more colonies were seen when using the primer-added reaction  to 
transform the E. coli, as compared to a transformation  using the 
unprimed reaction. 
The transformants were screened by digesting the DNA with 
BspE1, to verify that this new restriction site  was created at the 
site of the deletion.  The resultant plasmid was named pPD25 (Table 
1).  This mutation, designated virE2A1, was excised from pPD25  as a 
536 by Stul-BglIl restriction fragment and inserted into pGR1, 
replacing the corresponding wild-type fragment.  To verify that 77 
other alterations had not occurred during mutagenesis,  the insert
 
was sequenced by the Central Services Laboratory (Oregon State 
University). 
Construction of a virE2 null Strain of A.  tumefaciens 
An A. tumefaciens strain was created with virE2 deleted from 
the Ti plasmid to use as a background strain for virulence assays. 
This strain was transformed with broad host-range  plasmids 
containing either a wild-type virE2 gene  or plasmids with a mutant 
virE2 gene to assay for tumorigenesis. To create this  A. 
tumefaciens virE2 null strain, a deletion in  a cloned virE2 gene was 
first created in E. coll. The virE2 sequence was replaced with a gene 
encoding kanamycin resistance so that in a later step,  an A. 
tumefaciens strain containing the virE2 deletion could be selected 
by its resistance to kanamycin.  Details of the plasmid construction 
follow. 
The virE operon of pTiA6NC lies within a 3.2 kb Xhol 
restriction fragment (Garfinkel et al. 1981); this fragment  was 
inserted into the Sall site of pUC18 such that lacZ and virE are 
transcribed in the same direction in the resulting plasmid, pGR1 78 
(Sundberg et al. 1996). The 1497 by of the coding region of the virE2 
gene in pGR1 was replaced with the kanamycin resistance gene (neo) 
from Tn5 (Jorgenson et al. 1979).  This was accomplished by 
digesting pGR1 with Stul and Nael, purifying a 4.4 kb fragment of 
pGR1 from the 1,497 by fragment by 1%  agarose gel electrophoresis, 
and ligating a 2.4 kb blunt-ended Hindi restriction  fragment 
containing the neo gene from Tn5 (Jorgenson  et al. 1979) to the 4.4 
kb fragment.  The resulting plasmid, carrying the  substitution #1 
allele, pPD15 (Figure 3.2), contains  a single BamHI site which was 
used to insert pPD15 into the BamHI site of  broad-host-range 
plasmid pRK310 (Ditta et al. 1985) to form pPD16. 
We transformed pPD16 into the A. tumefaciens  strain A348 
which contains a wild-type Ti plasmid and used  a marker exchange 
procedure (Garfinkel et al. 1981; Miranda et al.  1992) to identify a 
homogenote (WR5000) carrying the kanamycin  resistant virE2 
substitution #1 allele in the Ti plasmid.  In the marker exchange 
procedure, a plasmid (pPH1JI) (Beringer et a/. 1978)  incompatible 
with the broad-host-range plasmid pRK310,  was transformed into 
A348 containing pPD16. The plasmid pPH1JI encodes gentamicin 
resistance.  To select for a recombination event between the virE 79 
operon on pPD16 and the virE operon on the Ti plasmid, we selected 
for kanamycin resistance (the virE2 deletion),  gentamicin resistance 
(pPH1JI), and screened for carbenicillin sensitivity (loss  of pPD16). 
We refer to the resulting A. tumefaciens strain  as WR5000. The 
structure of the Ti plasmid was verified by Southern blot analysis of 
genomic DNA after digestion with EcoR1 (Figures 3.2 and 3.3). 
Construction of A.  tumefaciens Strains for Virulence 
Assays 
The mutagenized pGR1 derivatives, pDP1 through pPD10 (Table 
2.1), were linearized at their single BamHl site and inserted  into the 
BamHl site of the broad-host-range plasmid pRK310. The  virE 
operon and the lacZ gene of pRK310 are transcribed in the same 
direction.  This resulted in plasmids pPD101 through pPD110  (Table 
2.1).  These plasmids were then used to transform the virE2 null 
strain WR5000, with selection for carbenicillin and kanamycin 
resistance, and also verification by Southern blot analysis (Figures 
3.4 and 3.5). 80 
Fusion of virE to an E. coli Promoter 
In order to assess the binding activities of the wild-type and 
mutant VirE2 proteins in E. coli extracts, the virE operon was fused 
to the trc  promoter in pTrc99A (Amann et al. 1988, this plasmid is 
available from Pharmacia).  The Sphl restriction site that lies 
outside the multiple cloning region of pTrc99A was first removed by 
performing a limited digestion of pTrc99A with Sphl, isolating full-
length linear plasmid DNA, and creating blunt ends by incubation 
with T4 DNA polymerase.  The blunt-ended DNA was ligated into 
circular molecules, and transformed into E. coli (Hanahan 1983). 
From among these transformants, we isolated pBL17, a pTrc99A 
derivative with a single Sphl site that lies in the multiple cloning 
region. We cleaved pBL17 with Ncol and Sphl and ligated to it an 
annealed pair of DNA oligonucleotides with Ncol and Sphl cohesive 
ends to create pWR223 (Figure 3.6).  The annealed oligonucleotides 
contain the first eight codons of virEl; the first codon (ATG) 
occupies the Ncol compatible end, and the sequence contains the only 
Sphl site within the virE operon.  Plasmid pGR1 contains two Sphl 
sites, one in virEl and another in the multiple cloning region of 
pUC18, beyond the 3' end of virE2. By inserting the 2.5 kb Sphl 81 
pUC18, beyond the 3' end of virE2. By inserting the 2.5 kb Sphl 
fragment into pWR223 (in the  proper orientation), we reconstructed 
the virE operon downstream of  a strong, lactose-inducible promoter, 
thereby creating pWR225.  Plasmids that contain mutant virE2  genes 
were made similarly (Table 2.1).  The plasmids were transformed 
into E. coli strain JC10,289 (Table 2.1). 
DNA Methods 
Rubidium Chloride Transformation of E.  coil 
This transformation method is based  on the work of Hanahan 
(1983).  Cells (MM294, DH5a, SK1592) were grown to a density of 5 x 
107 cells/ml (Klett 50-60) (5 ml  per transformation).  Cells were 
pelleted for 5 minutes at 13,000 x g at 25°C, resuspended  in 0.2 
volumes ice-cold RbCI buffer (100 mM RbCI, 45 mM MnCl2,  10 mM 
CaCl2, 35 mM KCH2COOH, 15% sucrose, pH 6.0 ), incubated on ice for 5 
minutes and resuspended in 0.04 volumes ice-cold RbCI buffer.  DNA 
(50 ng) was mixed with 200 IA competent cells and placed  on ice for 
60 minutes.  Cells were heat-shocked at 42°C for two minutes;  then 
diluted to 2.0 ml with L broth and incubated for 45 minutes at 37°C. 82 
Cells were then centrifuged at 2,000 x g for 5 minutes, plated  on L
 
agar containing appropriate antibiotics and incubated overnight at 
37°C. 
Calcium Chloride  A. tumefaciens  Transformation 
This transformation method is based  on the work of Holsters 
(1978).  Overnight cultures were used to inoculate 40 ml of YEP  and 
the cells were grown to a Klett reading of 100-150.  Cells were then 
pelleted at 2,600 x g for 7 minutes and resuspended in 0.5 volumes 
of ice-cold 150 mM NaCI. The cells were pelleted again and 
resuspended in 0.01 volumes ice-cold 75 mM CaCl2. DNA (10 14)  was 
added to 200 pl cells then the mixture was incubated for 30  minutes 
on ice and frozen in a dry ice/ethanol bath for three minutes.  Cells 
were heat-shocked at 37°C for five minutes then diluted into 10 ml 
YEP and incubated at 28°C with shaking for two hours.  Cells were 
again pelleted at 2,600 x g for 7 minutes, then plated  on AB glucose 
agar plates (Garfinkel et al. 1981) containing the appropriate 
antibiotics and incubated 2-3 days at 28°C. 83 
Plasmid DNA Miniprep (boiling method) 
E. coil cells were grown overnight, pelleted (1.5 ml per 
miniprep) for 2 minutes in a microfuge at 13,000 x g and 
resuspended in 300 pi STET (8% sucrose, 0.5% Triton X-100, 50 mM 
EDTA, 10 mM Tris-HCI (pH 8.0)).  Twenty-five µl of lysozyme 
solution (10 mg/ml in 10 mM Tris-HCI (pH 8.0)) was then added to 
each tube and the cells were incubated on ice for 10 minutes.  Cells 
were boiled 40 seconds and centrifuged 7 minutes at 13,000 x g. 
The white, stringy pellets were discarded and 300 III  isopropanol 
was added to each tube.  The supernatant was mixed with the 
isopropanol for 30 seconds by inverting several times.  The DNA was 
pelleted for 15 minutes at 13,000 x g and resuspended in sterile 
water.  To further purify the DNA, an equal volume of 
phenol/chloroform (1:1)  was added and the mixture was vortexed 
briefly prior to centrifuging for 5 minutes at 13,000 x g.  The top 
layer, containing the DNA, was removed to another microfuge tube 
and extracted with an equal volume of chloroform:isoamyl alcohol 
(24:1). The DNA was precipitated by adding 0.1 volume 8 M LiCI and 
2 volumes 100% ethanol and incubating at -20°C for 20 minutes. The 84 
DNA was pelleted by centrifugation at 13,000 x g, 15 minutes, and 
resuspended in sterile water. 
Ligation in Low Melt Agarose 
A 1% Sea Plaque (FMC Bioproducts) agarose gel in 1X TAE 
buffer (0.04 M Tris-acetate, 0.002 M EDTA (pH 8.1)) containing 0.5 
1.1g/m1 ethidium bromide was allowed to solidify at least one hour at 
4°C.  Digested DNA fragments (0.5-5 1.1.g digested DNA per lane) were 
subjected to electrophoresis through the gel at 75 mV. The DNA was 
visualized using a long-wavelength UV transilluminator and the 
bands of interest were excised from the gel.  The DNA-containing 
agarose was melted at 70°C for 5 minutes.  For a 20 ill  ligation 
reaction, 10 u.I molten agarose containing DNA was used. The 
reaction was incubated overnight at room temperature, heated for 5 
minutes at 70°C and 10 ill was used to transform E. coli as described 
previously. 85 
Southern Blot 
DNA (1-5 jig) was subjected to electrophoresis through an 0.8% 
agarose gel cast in 1X TBE buffer (0.045 M Tris-borate, 2 mM  EDTA 
(pH 8.4)) containing 0.5 jig/m1 ethidium bromide.  The gel was placed 
in a plastic container, covered with 0.25 N HCI,  and shaken gently for 
15 minutes, and then shaken with 0.4 M NaOH for 10 minutes. A 
piece of Gene Screen Plus nylon membrane (NEN  Research Products) 
was cut to the size of the gel, soaked in dH2O for 5 minutes and then 
soaked in 0.4 M NaOH for 10 minutes. The DNA in the gel was then 
transferred to the filter by a downward blotting  procedure for 2.5 
hours using a transfer solution of 0.4 M NaOH (Koetsier  et al. 1993). 
The membrane was rinsed in 2X SSC (0.3 M NaCI,  0.03 M sodium 
citrate) then incubated for 10 minutes at 37°C  to dry completely. 
The membrane was then placed in a hybridization tube containing 8 
ml FBI solution (0.5 M sodium phosphate (pH 7.5), 7% SDS) and 
incubated at 65°C for one hour. The FBI solution was discarded and 
three ml fresh FBI solution was added. 
DNA (1 jig) was labeled with [a-32P]dCTP (50 1.1Ci)  by nick 
translation (Bethesda Research Laboratories nick translation 
system) (Ausubel et al. 1987).  The unincorporated deoxynucleoside 86 
triphosphates were removed using a spin column. A 0.9 ml column of 
G50 Superfine (Sephadex) was prepared in a 1 ml syringe containing 
a plug of siliconized glass wool at the bottom.  The Sephadex was 
equilibrated in TE (10 mM Tris-HC1 (pH 8.0), 1 mm EDTA) prior to 
use. The syringe was filled with Sephadex to 1 ml volume and 
centrifuged at 2,900 RPM for 2.5 minutes in a Beckman GH-3.7 rotor. 
This process was repeated 2 or 3 times until a column volume of 0.9 
ml was obtained after centrifugation.  The nick translation reaction 
was applied to the top of the column and the centrifugation repeated 
as above.  The unincorporated nucleotides remained in the column 
after centrifugation.  Using this method typical specific activities 
of 3 x 106 cpm per 1.tg of DNA were obtained and approximately 0.3 1.ig 
of probe DNA was added to 0.5 ml FBI solution. To denature the 
labeled DNA, the DNA/FBI solution was boiled for 3 minutes before 
being added to the membrane. The membrane was then incubated at 
65°C overnight. 
The membrane was rinsed briefly in 15 ml of 2X SSC plus SDS 
(0.3 M NaCI, 30 mM sodium citrate, 1% SDS) and then washed twice 
with 15 ml 0.2X SSC plus SDS (0.03 M NaCI, 3 mM sodium citrate, 1% 
SDS) at 65°C for 30 minutes. The membrane was allowed to air dry 87 
and exposed to Kodak X-Omat AR film at -80°C with  an intensifying 
screen. 
DNA Fragment Purification from  an Agarose Gel for
Probe Synthesis 
A 517 base pair (bp) DNA fragment was purified from a Hinf1 
restriction digest of 8 lig of pUC18.  Fifty ng of this DNA was end-
labeled in 40 ul of buffer consisting of 0.25 mM dTTP,  0.25 mM dCTP, 
0.25 mM dGTP, 2.5 units E. coli DNA polymerase I, Large fragment 
(New England Biolabs), 50 mei of [a-32P]dATP, 50 mM  potassium 
phosphate (pH 7.5), 3 mM MgCl2 and 1 mM 2-mercapto-ethanol.  The 
reaction was incubated for five minutes at  room temperature and 
the enzyme was inactivated by adding 1µl of 0.5 M EDTA (pH 8.0) and 
heating to 75°C for 10 minutes. The unincorporated  deoxynucleoside 
triphosphates were removed using a spin column  as described 
previously. The DNA was precipitated by adding 0.5 volumes of  7.5 M 
ammonium acetate and 2 volumes of 100% ethanol, and placing at 
-20°C for 20 minutes. The DNA was pelleted at 13,000 x g for 30 
minutes at 4°C and resuspended in TE (10 mM Tris-HCI (pH  8.0), 1 mM 
EDTA). 88 
This 517 by fragment was isolated from  an agarose gel as 
described in the ligation in low melt agarose section (see  DNA 
methods, section 2.3).  The agarose gel was melted at 70°C for 5 
minutes, three volumes of TE (10 mM Tris-HCI (pH 8), 1 mM  EDTA (pH 
8.0)) were added, and the mixture was incubated for 5  minutes at 
70°C.  The mixture was vortexed briefly, frozen at -80°C for 5 
minutes and thawed at room temperature.  After thawing, the tube 
was tapped vigorously against the lab bench a few times and 
centrifuged at 13,000 x g for 5 minutes.  The supernatant was 
removed and the DNA precipitated by adding 0.1 volume of 8 M  LiCI 
and 2 volumes of 100% ethanol, then incubating at -80°C for 20 
minutes. The DNA was pelleted by centrifugation at 25°C (15 
minutes, 13,000 x g).  To precipitate fragments less than 1  kb, the 
DNA was incubated in LiCI plus ethanol overnight at -20°C, and 
centrifuged at 4°C for 30 minutes at 13,000 x g. 89 
Virulence Assays 
Potato Disc Assay 
For quantitative virulence assays, potato tuber discs (7  mm 
diameter) were inoculated by the method of Shurvinton and Ream 
(1991).  A brief description follows.  Five ml cultures of A. 
tumefaciens strains in YEP broth with appropriate antibiotics  were 
grown with shaking at 28°C, and 100 RI of each overnight culture 
was diluted with 900 gl phosphate buffered saline (3 mM sodium 
phosphate dibasic, 10 mM potassium phosphate monobasic, 12 mM 
sodium chloride pH 7.2).  Red, organic potatoes were removed from 
the cold room and allowed to warm overnight to room temperature. 
Organic potatoes are more susceptible to infection by A. 
tumefaciens than potatoes treated with sprout-inhibiting chemicals. 
Potatoes were peeled and surface-sterilized for 10 minutes in a 20% 
bleach solution. 
Using a laminar flow hood to prevent contamination, the potato 
was rinsed thoroughly with sterile water and placed on a sterile 
paper towel.  Using a sterilized cork borer (7 mm diameter) and 
glass pipette (to push cores out of borer) the potatoes were cored 90 
and sliced into discs 3-4 mm thick.  A large potato yielded about 10 
cores and 80 discs.  The last 3-4 discs at the core ends were not 
used as they had been in contact with the bleach solution.  The discs 
were placed on water agar plates (7.5 gm agar per 500 ml water) 
using sterile tweezers.  Ten ill (2 x 10 7 cfu) of a diluted A. 
tumefaciens strain was placed on each separate disc.  Parafilm was 
wrapped around the edge of each covered plate to  prevent the agar 
from drying out, and the plates were incubated  at 28°C for three 
weeks.  The tumors appeared as white crystalline protrusions  and 
were counted using a dissecting microscope. 
Carrot Slice Assay 
An assay similar to the potato assay was used for  carrots. 
Organic carrots (grown without pesticides  or herbicides) with green 
leafy tops gave the best results.  After sterilization and rinsing, 
carrots were sliced and placed on water agar plates facing upwards 
on the agar in the direction they grew in the soil.  The meristem 
surrounding the core of each slice was inoculated with 10 gl  of PBS-
diluted bacteria (2 x 10 7 cfu).  Comparison between different A. 91 
tumefaciens strains was made using discs from the  same carrot. 
Tumors arose from the meristemmatic tissue  surrounding the core 
of each slice as callous-like material; the individual  tumors were 
indistinguishable and therefore only qualitative virulence  results 
could be obtained.  The tumors were scored after three weeks. 
Kaianchoe daigremontiana and Tomato  Assays 
K. daigremontiana leaves and tomato stems (cv.  Bonnie Best) 
were infected by wounding the tissue with a sterile toothpick  and 
packing wounds with A. tumefaciens cells cultured  on AB glucose 
agar plates (Garfinkel et al. 1981) containing appropriate 
antibiotics.  The K. daigremontiana leaves and tomato  stems were 
scored after four weeks. 
Protein Methods 
Preparation of VirE2 from E. coli Extracts 
Twenty ml cultures of E. coli, harboring wild-type  or mutant 
virE2 in pBL17, were grown at 37°C with aeration in  L-broth to an 
optical cell density (A595) of 0.7. The trc promoter was induced by 92 
the addition of IPTG (0.5 mM final concentration), and incubation 
continued for three hours.  Cells were harvested by centrifugation 
(10,800 x g, 4°C), resuspended in 1.5 ml ice-cold Buffer A (10 mM 
Tris-HCI pH 8.0, 10% v/v glycerol, 25 mM sodium chloride, 1 mM 
phenyl methyl sulfonyl fluoride [PMSF], 1mM dithiothreitol), and 
lysed in a French press at 19,600 pounds per square inch (PSI).  The 
lysates were centrifuged at 17,000 x g at 4°C for 6 minutes and 50 
IA aliquots of the supernatant were frozen at -80°C.  The soluble 
VirE2 protein in these supernatants was used to determine the DNA 
binding affinities of the wild-type and mutant VirE2 proteins.  The 
insoluble VirE2 protein in the pellet was purified by electroelution 
from an SDS-polyacrylamide gel.  This purification is described in 
the next section.  The protein concentration in each extract was 
determined using the Bradford dye-binding procedure with a bovine 
serum albumin standard curve (Bradford 1976; Bio-Rad).  The total 
protein concentrations obtained were between 4.0-6.5 mg/ml. 
VirE2  Protein  Purification 
To prepare homogeneous VirE2 protein to estimate the VirE2 
concentrations by immunoblot analysis, the insoluble VirE2 protein 93 
in the pellet was purified by electroelution from a 10% SDS­
polyacrylamide gel.  This insoluble VirE2 protein was resistant to 
protease degradation in E. coli VirE2 protein was solubilized by 
resuspending the pellet in 1.5 ml ice-cold buffer containing urea (10 
mM Tris-HCI (pH 8.0), 10% v/v glycerol, 1 M sodium chloride, 1 mM 
phenyl methyl sulfonyl fluoride [PMSF], 1 mM dithiothreitol, 4 M 
urea) and incubated on ice for 30 minutes.  After centrifugation 
(17,000 x g, at 4°C for 6 minutes) the supernatant was dialyzed for 
2 hours at 4°C against 2 liters of buffer A (10 mM Tris-HCI (pH 8.0), 
10% (v/v) glycerol, 25 mM sodium chloride,  1 mM dithiothreitol) and 
then overnight at 4°C against 2 liters of fresh buffer A.  After 
dialysis, the soluble protein was frozen at -80°C.  The soluble 
protein was subjected to electrophoresis through a 10% SDS­
polyacrylamide gel, the gel was stained with 0.05% Coomassie blue 
G250 in water, destained in water, and the VirE2 containing band 
was excised.  The gel slice was chopped into smaller pieces and 
VirE2 was electroeluted in  liter tris/glycine buffer (2 liters dH20 , 1 
9.94 g tris base, 57.6 g glycine, 2 g SDS) using an Elutrap 
electroelution apparatus (Schleicher and Schuell) for 3 hours at 4°C 
and 150 mV.  The concentration of VirE2 purified by electroelution 94 
was determined by gel electrophoresis.  A known volume (10 ul) of 
the electroeluted protein was subjected to electrophoresis through  a 
10% SDS polyacrylamide gel next to a known concentration  range 
(0.23 ng/ul to 6.0 ng/ul) of bovine serum albumin (BSA).  After silver 
staining, the band intensity of each protein was determined using  a 
Molecular Dynamics densitometer coupled to ImageQuant software, 
which generated a standard curve for the concentration of BSA.  This 
standard curve was used to estimate the concentration of the 
purified VirE2, which was determined to be 3.8 ng per pi  .  The 
purified VirE2 protein did not retain ssDNA-binding activity. 
Determination  of VirE2 Concentration 
The concentration of the overexpressed VirE2 protein in crude 
E. coli extracts was determined immunologically, similarly to the 
procedure described by Ausubel et al. 1987, using a standard curve 
of purified VirE2. 
Varying amounts of purified VirE2 (ranging from 1.6 to 11.4 
ng) were subjected to electrophoresis through a 10% polyacrylamide 
gel to generate a linear standard curve.  Aliquots of cellular 
extracts were loaded on the same gel and proteins from the gel were 95 
electrophoretically transferred to a nitrocellulose  membrane 
(Schleicher and Schuell)  for 75 minutes at 50 mAmps using a Hoefer 
semi-dry transfer apparatus (Ausubel et al. 1987).  The transfer 
buffer consisted of 400 ml 10X Transfer Buffer Concentrate  (1  liter 
dH2O, 14.5 g tris base, 67 g glycine), 800 ml methanol  and 2.8 liters 
dH2O. The membrane was incubated for 30 minutes in 15 ml MTBS 
(20 mM Tris-HCI pH 7.5, 500 mM sodium chloride, 5% (w/v) Carnation 
nonfat dry milk) at room temperature with gentle agitation.  A 1:80 
dilution of E. coil extract (Promega) in 15 ml TTBS (20 mM Tris-HC1 
pH 7.5, 500 mM sodium chloride, 0.1% Tween 20) was incubated with 
a 1:4,000 dilution of polyclonal rabbit antiserum raised against 
VirE2 (Das 1988) for 30 minutes at 37°. The MTBS  solution was 
discarded from the membrane and the VirE2 antiserum in the  TTBS 
solution was added.  After incubation for 45 minutes at  room 
temperature with gentle agitation, the membrane  was washed twice 
(5 minutes each) with 15 ml TTBS at room temperature  with gentle 
agitation.  The membrane was then incubated for 45 minutes with  15 
ml of a 1:5000 dilution of goat anti-rabbit horseradish peroxidase 
(GAR-HRP) (Bio-Rad) in MTTBS (20 mM Tris-HCI pH 7.5, 500 mM 
sodium chloride, 0.1% Tween 20, 5% (w/v) Carnation nonfat  dry milk) 96 
at room temperature with gentle agitation.  The membrane was 
washed twice in 30 ml TTBS at room temperature  with gentle 
agitation (5 minutes each) and then washed twice in  30 ml TBS at 
room temperature with gentle agitation (10 minutes each).  The HRP 
was detected with an ECL Western blot chemiluminescence 
development kit (Amersham).  To quantitate light emissions, flashed 
X-ray film (the film was flashed from a distance of 9 feet) was 
exposed to the filters, and the resulting band intensity  measured on 
a Molecular Dynamics densitometer interfaced to ImageQuant 
software.  For each immunoblot, a standard  curve was generated 
from the purified VirE2 data and the amount in each  cellular extract 
was estimated. 
DNA Binding Assays 
To locate domains important for DNA binding,  we assessed the 
ssDNA binding activity of each VirE2 mutant. A 517-bp  HinFl 
fragment from pUC18 was labeled using the Klenow fragment  of DNA 
polymerase I (New England Biolabs) and [a -32P]dATP; the labeled 
DNA was boiled prior to use to denature the double-stranded  DNA. 97 
E. coli extracts containing VirE2 extracts containing  VirE2 
(10-71 ng/ul) were mixed with  1 ng of 32P-labeled ssDNA (10 pil 
total volume), and incubated for ten minutes  on ice.  Loading buffer 
(3 IA of 10% v/v glycerol 0.1% bromphenol blue)  was added prior to 
electrophoresis on a 4% polyacrylamide gel, cast in low ionic-
strength buffer (6.7 mM Tris-HCI (pH 7.5), 1 mM EDTA, 3.3 mM 
sodium acetate).  A potential of 75 volts was applied to the gel for 
15 minutes at 4° C prior to loading the samples and for 75  minutes 
after loading. The gel was dried and exposed to  a phosphorimager 
screen.  Signals were quantitated using a Molecular Dynamics 
phosphorimager with ImageQuant software. 98 
CHAPTER 3.  RESULTS
 
Construction of  virE2  Mutants 
The results of the linker insertion mutagenesis of virE2 and 
the location of the ten amino acid deletion  are shown in Figure 3.1. 
The two nuclear localization sequences in virE2  are also shown. 
Changes in the amino acid sequence as a  consequence of the linker 
insertions are described in the legend to Figure 3.1. The 30 by 
deletion was located between insertion 1 and 2 near the amino 
terminus. 
Construction of the  virE2  Null  A.  tumefaciens  Strain 
The  virE2 null A.  tumefaciens  strain was constructed using 
marker exchange as described in Experimental Procedures and the 
final construct is shown in Figure 3.2.  A 1.5 kb segment of virE2 
was replaced by a 2.4 kb fragment encoding the kanamycin 
resistance gene (neo). This resulted in a change in the EcoR 1 
restriction sites at this locus (Figure 3.2). 99 
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Figure 3.1.  Map of mutations in virE2.  NLS=nuclear 
localization signal, NLS 1= 205- KLR PED RYV QTE RYG PR -226  NLS 
2= 273 -KRR YGG ETE IKL KSK -287  The basic amino acids in the nuclear 
localization sequences are underlined.  .6,  =the deletion of residues 
56-65 (SSSLY SGSEH) from virE2  L=leucine, E=glutamic acid, 
S=serine, R=arginine, D=aspartic acid, A=alanine, P=proline, 
Y=tyrosine V=valine Q=glutamine, T=threonine, G=glycine, K=lysine. 
Insertion 1=LE; Insertion 2 =SS; Insertion 3=SR; Insertion 4=LE; 
Insertion 5=SS; Insertion 6=the replacement of residue 472,  a 
tyrosine by a serine and the insertion of an arginine and aspartic 
acid after residue 472; Insertion 7=RA; Insertion 8=SR.  The deletion 
was created using site-directed mutagenesis as described in the 
experimental procedures chapter (see DNA methods in section 2.3). 
Linker insertion mutagenesis is also described in the chapter  on 
experimental procedures (see DNA methods in section 2.3). 100
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Figure 3.2.  Replacement of virE2 with  neo from Tn5 and a 
Map of the  virE2 null A.  tumefaciens strain.  A)  Numbers 
indicate codons in the wild-type virE2  gene.  Arrows indicate the 
direction of transcription.  Restriction sites used in the 
construction of pPD15 are indicated  B)  Strain A348 has a wild-type
Ti plasmid.  In WR5000, the virE2 gene  on the Ti plasmid is replaced
by the neo gene encoding resistance to kanamycin. The  EcoR I 
restriction sites are shown. 101 
The integrity of the Ti plasmid in the A. tumefaciens virE2  null 
strain WR5000 was verified by Southern blot analysis (Figure 3.3). 
Genomic DNA from the A. tumefaciens transformants  was digested 
with EcoR1 and probed with nick-translated pGR1 which contains the 
virE operon.  This probe will hybridize to the regions flanking the 
virE2 gene (Figure 3.2). The wild-type virE2 gene has one EcoR1 
restriction site which was removed by insertion of the kanamycin 
resistance gene. When digested with EcoR1, two fragments (2.4 kb 
and 4.0 kb) of the wild-type gene (bands B and C) hybridize to the 
probe, whereas the mutant has a single band of 7.3 kb (A) that 
hybridizes to the probe because the neo gene does not contain  any 
EcoR1 sites. 
Construction of the A.  tumefaciens Strains Used For 
Virulence Assays 
After verifying the absence of the virE2 gene from the null 
strain WR5000 (Figure 3.3), this strain was transformed with 
plasmids encoding wild-type or mutant forms of virE2.  Strain 
WR5000 was transformed with plasmids pPD100 through pPD110 102 
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Figure 3.3. Southern blot analysis of virE2 null A. 
tumefaciens strain WR5000. 
Lane 1. X Hindlll ladder 
Lane 2.  strain A348 which harbors a 
wild-type Ti plasmid-pTiA6NC 
Lanes 3-4. strain WR5000 isolates harboring a Ti plasmid 
with neo from Tn5 replacing virE2 on pTiA6NC 
A. tumefaciens DNA was prepared, digested with EcoR1, and 
probed with pGR1. Note the disappearance of bands B and C 
(seen in lane 2) and the appearance of a larger band 
(A) in lanes 3 and 4. The EcoR1 site in virE2 on the Ti 
plasmid was eliminated due to its replacement by neo. 103 
(Table 2.1), yielding A tumefaciens strains designated WR5100
 
through WR5110 (Table 2.1). 
To verify the integrity of these plasmids, Southern blot 
analysis was performed (Figure 3.4).  Genomic DNA was digested 
with BamH1 and Xho1 and probed with pGR1, which contains the virE 
operon. The mutagenized pGR1 derivatives, pPD1 through pPD10 
(Table 2.1), were linearized at their single BamH1 site and inserted 
into the BamH1 site of the broad host range plasmid pRK310 to yield 
plasmids pPD101 through pPD110.  Therefore, a BamH1 digest will 
cut the plasmids pPD101 through pPD110 twice resulting in two 
fragments. One fragment (20.4 kb) will be pRK310 which does not 
hybridize to pGR1 and therefore will not be detected. The second 
fragment, containing the virE operon in pUC18 will be detected 
(Figure 3.5). 
BamH1 cuts once in the multiple cloning site in pUC18, 900 
base pairs (bp) upstream from the start of the virE2 gene Xho1 cuts 
only at the site of the linker insertion (Figure 3.5).  An Xho1 and 
BamH1 digest of a wild-type virE2 gene results in the detection of a 
single fragment, whereas a similar digest of a linker insertion 104 
1  2  3 4 5  6  7 8 9 10 
kb 
12.2 
5.0 
4.0  4.411411.40.1111100.4 
3.0 
2.0 
1.6 
1.0 
0.5  a 
Figure 3.4. Southern blot analysis of A. 
tumefaciens strains with mutations in virE2. 
Total genomic A. tumefaciens DNA was prepared, 
digested with Xhol  and  BamHl,  and probed with 
pGR1. A second band appears in the strains 
containing an  Xhol  linker insertion in  virE2. 
Lane 1.  1 kb ladder 
Lane 2. strain WR5100 
strain WR100 = pPD100 (WT virE2)  in WR5000 
Lanes 3 -10. strains WR5101  WR5108 
strains WR5101  WR5108 = pPD101- PPD108 
(virE2 linker insertion mutants) in WR5000 105 
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Figure 3.5.  Map of the virE gene cloned into pUC18. Numbers 
1-8 show the positions of the Xhol linker insertions.  The location 
of the unique BamH1 site used for Southern analysis is shown. 106 
mutant results in the detection of two fragments due to the 
presence of an Xhol site in the linker insertion. 
The sizes of the fragments expected from insertions 1 through 
8 were confirmed in this analysis, thereby confirming the location 
of the insertions. Furthermore, the locations of the mutations were 
also confirmed by sequencing (Central Services Lab, Oregon State 
University). 
Determination of VirE2 Protein Concentration in  E. coil 
Extracts 
To determine the binding activities of the wild-type and 
mutant VirE2 proteins, the virE operon was inserted into pTrc99A 
(Amann et al. 1988) which resulted in the expression of VirE2 in E. 
coli.  As described in the chapter on Experimental Procedures, this 
cloning was facilitated by inserting a pair of oligonucleotide linkers 
into a derivative of pTrc99A (pBL17) as shown in Figure 3.6. 
The VirE2 protein concentration in  E. coli  extracts was 
estimated using immunoblot analysis and purified VirE2 protein as 
described in Chapter 2 (see protein methods, section 2.5).  The 
Immunoblots and the relationship between the amount of purified 107 
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Figure 3.6.  Construction of pWR223.  Oligonucleotide  linkers 
containing the first seven codons of virEl were ligated into a 
pTrc99A expression vector to facilitate the expression of virE in E. 
con.  M=methionine A=alanine  l= isoleucine  K=lysine  P=proline 
H=histidine 108 
VirE2 protein and the signal obtained from the densitometer  are
 
presented are shown in Figures 3.7 through 3.12. A fraction of the 
soluble VirE2 protein produced in E. coli was cleaved by a protease. 
Therefore, the antibody recognized two species: full length VirE2 
(approximately 66 kDa on an SDS-PAGE gel) and  a slightly smaller 
VirE2 species (approximately 64 kDa on an SDS-PAGE gel) which 
migrated as a separate band (Figures 3.7, 3.9 and 3.11). 
The signals from both bands were used to estimate the 
amount of VirE2 protein.  In most cases, approximately half of the 
VirE2 protein produced was cleaved, except for VirE2 mutants with 
insertions 2, 7, and 8.  In the case of insertions 7 and 8, the 
majority of VirE2 protein produced was cleaved, whereas insertion 2 
rendered VirE2 resistant to the protease. 109 
Figure 3.7.  Immunoblot analysis of protein extracts from
E. coli with mutations in virE2.  Purified VirE2 (lanes 1-3) or E. 
coli extracts overexpressing VirE2  were transferred to 
nitrocellulose and immunologically detected with  antiVirE2 serum. 
The blot was developed using goat anti-rabbit  horseradish 
peroxidase and an ECL chemiluminescence development kit 
(Amersham). A standard curve was generated from  the signal 
emitted in lanes 1, 2, and 3.  This standard curve is shown in Figure 
3.8.  This relationship was used to estimate the  amounts of VirE2 
protein in the E. coli extracts (lanes 4-8).  Only uncleaved VirE2 
protein is seen in the purified standards in lanes 1, 2,  and 3.  The 
cleaved VirE2 protein, VirE2', is seen in lanes 4, 5, 6,  and 8.  The 
signal from both bands was used to estimate the amount of VirE2 
protein in each extract.  Only the cleaved product, VirE2', is seen in 
lane 7. The signal in lane 4 is outside the linear range of the ECL 
system, and therefore this estimate was not used.  A smaller volume 
of this extract was immunoblotted again  so that the signal was 
within the linear range and this signal  was used to estimate the 
amount of VirE2 protein in the Mutant 5 extract. 
Lane 1.  3.8 ng purified VirE2 
Lane 2.  7.6 ng purified VirE2 
Lane 3. 11.4 ng purified VirE2 
Lane 4. 13.5 ng Mutant 5 
Lane 5.  6.5 ng Mutant 3 
Lane 6.  6.5 ng Mutant 6 
Lane 7. 4.6 ng Mutant 7 
Lane 8.  5.3 ng Deletion 110 
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Figure 3.8.  Absorbance of purified VirE2 standards in 
immunoblot analysis of E. coil extracts.  The signal in lanes 1, 
2, and 3 from Figure 3.7 was measured on a Molecular Dynamics 
densitometer interfaced with ImageQuant software.  The signal 
obtained is plotted versus the amount of VirE2 protein loaded in 
each lane.  This curve was used to determine the amount of VirE2 
protein in the E. coli cell extracts (lanes 4-8 Figure 3.7). 112 
Figure 3.9.  Immunoblot analysis of protein extracts from
E. coil with mutations in virE2.  Purified VirE2 (lanes 1-3) or E. 
coli extracts overexpressing VirE2 were transferred  to 
nitrocellulose and immunologically detected with antiVirE2  serum. 
The blot was developed using goat anti-rabbit horseradish 
peroxidase and an ECL chemiluminescence development kit 
(Amersham). A standard curve was generated from the signal 
emitted in lanes 1, 2, and 3.  This standard curve is shown in Figure 
3.10.  This relationship was used to estimate the  amounts of VirE2 
protein in the E. coli extracts (lanes 4-8).  Only uncleaved VirE2 
protein is seen in the purified standards in lanes 1, 2, and 3.  The 
cleaved VirE2 protein, VirE2', is seen in lane 7.  The signal from both 
bands was used to estimate the amount of VirE2 protein in this 
extract.  Only the cleaved product, VirE2', is seen in lanes 6 and 7. 
Lane 1. 3.8 ng purified VirE2 
Lane 2. 7.6 ng purified VirE2 
Lane 3. 11.4 ng purified VirE2 
Lane 4. 3.3 ng Mutant 5 
Lane 5. 7.1 ng Mutant 8 
Lane 6. 12.1 ng Mutant 8 
Lane 7. 4.8 ng Mutant 4 113 
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Figure 3.10.  Absorbance of purified VirE2 standards in
immunoblot analysis of E. coil extracts.  The signal in lanes 1, 
2, and 3 from Figure 3.9 was measured on a Molecular Dynamics 
densitometer interfaced with lmageQuant software.  The signal 
obtained is plotted versus the amount of VirE2 protein loaded in 
each lane.  This curve was used to determine the amount of VirE2 
protein in the E. coli cell extracts (lanes 4-7 Figure 3.9). 115 
Figure 3.11.  Immunoblot analysis of protein
extracts from  E.  coli with mutations in  virE2.  Purified VirE2 
(lanes 1-3) or E. coli extracts overexpressing  VirE2 were 
transferred to nitrocellulose and immunologically  detected with 
antiVirE2 serum.  The blot was developed using goat  anti-rabbit 
horseradish peroxidase and an ECL  chemiluminescence development
kit (Amersham). A standard  curve was generated from the signal 
emitted in lanes 1, 2, 3, and 4.  This standard curve is shown in 
Figure 3.12.  This relationship was used to estimate the amounts of 
VirE2 protein in the E. coli extracts (lanes 5-9).  Only uncleaved 
VirE2 protein is seen in the purified standards  in lanes 1, 2, 3, and 4. 
The cleaved VirE2 protein, VirE2', is  seen in lanes 5-8.  The signal 
from both bands was used to estimate the  amount of VirE2 protein in 
each extract.  Only uncleaved VirE2 is seen in lane 9. 
Lane 1. 1.9 ng purified VirE2 
Lane 2. 3.8 ng purified VirE2 
Lane 3. 7.6 ng purified VirE2 
Lane 4. 11.4 ng purified VirE2 
Lane 5. 4.9 ng wild-type 
Lane 6. 1.5 ng wild-type 
Lane 7. 4.2 ng Mutant 1 
Lane 8. 1.5 ng Mutant 1 
Lane 9. 8.0 ng Mutant 2 116 
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Figure 3.12.  Absorbance of purified VirE2 standards in
immunoblot analysis of E. coli extracts.  The signal in lanes 1, 
2, 3, and 4 from Figure 3.11 was measured on a Molecular Dynamics 
densitometer interfaced with lmageQuant software.  The signal 
obtained is plotted versus the amount of VirE2 protein loaded in 
each lane.  This curve was used to determine the amount of VirE2 
protein in the E. coli cell extracts (lanes 5-9, Figure 3.11). 118 
Virulence  Data 
Potato  Inoculations 
Potato discs were photographed three weeks after  inoculation 
with A. tumefaciens (Figure 3.13).  Disease incidence for each 
mutant is presented in Figure 3.14.  For each mutant, the wild-type 
strain (WR5100) was used as a control to inoculate discs from the 
same potato.  As depicted in Figure 3.14, five of the mutations 
resulted in a substantial decrease in virulence whereas four  did not, 
determined by the number of tumors formed  on the potato discs 
compared to wild-type. These data are summarized in Table 3.1. 
Insertions 1, 2, 4, 5 and 6 resulted in less than 5% of wild-type 
virulence (Figure 3.13).  Insertions 3, 7 and 8 are similar in 
virulence phenotype and resulted in 37 to 47% wild-type  virulence. 
The virulence of the deletion mutant most closely matched the 
virulence of the wild-type strain, with 67% wild-type virulence.  A 
student's t-test (Langley 1971) indicated the relative virulence of 
each of the mutants was significantly different from wild-type 
(P<0.01). 119 
Figure 3.13. Potato discs infected with A.  tumefaciens 
mutants.  Potato discs were infected with wild-type (WR5100)  and 
mutant A. tumefaciens strains.  After three weeks the tumors were 
counted using a light microscope.  A)Virulence of mutant 1 (WR5101) 
and wild-type (WR5100)  B)Virulence of mutant  2 (WR5102) and 
wild-type (WR5100)  C)Virulence of mutant 5 (WR5105) and wild-
type (WR5100)  D)Virulence of mutant 3 (WR5103), wild-type 
(WR5100), mutant 8 (WR5108), and mutant 7 (WR5107)  E)Virulence 
of mutant 6 (WR5106) and wild-type (WR5100)  F)Virulence of wild-
type (WR5100) and mutant 4 (WR5104)  G)Virulence of wild-type 
(WR5100) and the deletion (WR5110). 120 
A)  mutant 1  wild-type 
B)  mutant 2  wild-type 
C)  mutant 5  wild-type 
Figure  3.13
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D)  mutant 3  wild-type 
mutant 8  mutant 7
 
E)  mutant 6  wild-type 
Figure 3.13 (continued)
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Fig. 3.14. Effect of mutations in virE2 on the virulence of
A. tumefaciens  strains on potato discs.  Potato discs were 
infected with A.  tumefaciens.  After three weeks, the tumors  were 
counted using a light microscope. 124 
Table 3.1.  Virulence of strains with mutations in virE2 on potato 
discs. 
Strain	  virE2  Disks  Average  Relative 
allele  tumors per disk  virulence 
WR5100  +  548  8.3 ± 8.8  100 
WR5101  ins.  1  125  0.37 ± 0.7  4.5 
WR5102  ins. 2  123  0.02 ± 0.15  0.24 
WR5103  ins. 3  174  3.9 ± 4.8  47 
WR5104  ins. 4  273  0.05 ± 0.3  0.60 
WR5105  ins. 5  79  0.04 ± 0.19  0.48 
WR5106  ins. 6  88  0.13 ± 0.47  1.6 
WR5107  ins. 7  133  3.5 ± 4.7  42 
WR5108  ins. 8  140  3.1 ± 4.7,  37 
WR5110  del. 1  300  5.5 ± 6.7  66 125 
Carrot  Inoculations 
Because a ring of tumor tissue  arose at the meristem, the 
carrot assays yield only qualitative results, which  are depicted in 
Figure 3.15.  Carrot slices from the same carrot, infected  with the 
wild-type strain (WR5100) are also shown for  comparison.  Strains 
with decreased virulence on the potato discs,  also had reduced 
virulence on the carrot slices.  Insertion mutants 1, 2, 4, 5, and 6 
had severely reduced virulence on the  carrot slices; very few or no 
tumors were seen.  Insertion mutants 7 and 8 had reduced  virulence 
compared to infection with the wild-type strain,  while the deletion 
mutant and insertion mutant 3 had virulence  phenotypes that were 
similar to  wild-type. 126 
Figure 3.15. Carrot slices infected with  A.  tumefaciens
 
mutants.  Carrot slices were infected with wild-type (WR5100)  and
 
mutant A. tumefaciens strains.  After three weeks the tumors  were
 
scored.
 
A)Virulence  of wild-type  (WR5100)  and mutant 1  (WR5101)
 
B)Virulence  of wild-type  (WR5100)  and mutant 2  (WR5102)
 
C)Virulence  of wild-type  (WR5100)  and mutant 3  (WR5103)
 
D)Virulence  of wild-type  (WR5100)  and mutant 4  (WR5104)
 
E)Virulence  of wild-type  (WR5100)  and mutant 5  (WR5105)
 
F)Virulence  of wild-type  (WR5100)  and mutant 6  (WR5106)
 
G)Virulence  of wild-type  (WR5100)  and mutant 7  (WR5107)
 
H)Virulence  of wild-type  (WR5100)  and mutant 8  (WR5108)

I) Virulence  of wild-type  (WR5100)  and deletion  (WR5110)
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A)  wild-type  mutant 1 
B)  wild-type  mutant 2
 
C)  wild-type  mutant 3
 
Figure  3.15
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D)  wild-type  mutant 4 
E)  wild-type  mutant 5
 
F)  wild-type  mutant 6
 
Figure  3.15 (continued)
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G)  wild-type  mutant 7 
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Figure 3.15 (continued)
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Kalanchoe daigremontiana Inoculations 
K. daigremontiana leaves were wounded, inoculated with wild-
type or mutant A. tumefaciens strains and scored for tumors after 
four weeks.  The positive control strains used were A348 and 
WR5100.  Strain A348 has a wild-type Ti plasmid, whereas WR5100 
has the virE2 gene deleted from the Ti plasmid and replaced with the 
neo gene encoding kanamycin resistance. WR5100 also harbors a 
broad-host-range plasmid expressing a wild-type copy of virE2. K. 
daigremontiana leaves were also inoculated with the negative 
control strains WR5000 and WR3095.  Strain WR3095 has both of the 
right border regions located next to the transferred DNA (T-DNA) 
regions deleted from the Ti plasmid.  A wound-only uninoculated 
control was also included on each leaf. 
Mutants 2, 5, and 6 had severely reduced virulence on K. 
daigremontiana as shown in Figure 3.16.  Mutant 4 had reduced 
virulence and formed smaller tumors compared to wild-type.  The 
virulence phenotype of mutant 1 was inconsistent and tumors that 
varied from smaller than wild-type to wild-type in size were 
formed.  Mutants 3, 7, 8, and the deletion were fully virulent, and 
produced tumors similar in size to wild-type. 131 
Figure 3.16.  Kalanchoe daigremontiana  leaves infected with 
A.  tumetaciens  mutants. K.  daigremontianaleaves were wounded 
and infected with wild-type and mutant A.  tumefaciens strains. 
Leaves were photographed after four weeks.  Positive control 
strains included A348, with wild-type virE2  on the Ti plasmid, and 
WR5100, containing a deletion of virE2 from the Ti plasmid and a 
broad-host-range plasmid containing  a wild-type copy of  virE2. 
Negative controls included WR5000, containing  a deletion of virE2 on 
the Ti plasmid and WR3095, which has both of the right-border 
repeats of the T-DNA regions deleted from the Ti  plasmid.
A) top of leaf:  wild-type (WR5100), wild-type (A348),  negative
control (WR5000), negative control (WR3095),  wound only 
bottom of leaf: mutant 1 (WR5101), mutant 8  (WR5108), mutant 5
(WR5105), mutant 4 (WR5104), deletion (WR5110) 
B) top of leaf: mutant 6 (WR5106), mutant 3  (WR5103), mutant 2
(WR5102), mutant 7(WR5107) 
bottom of leaf:  wild-type (WR5100), wild-type (A348),  negative
control (WR5000), negative control (WR3095),  wound only 132 
A)  positive  controls  negative controls 
WR5100  A348  WR5000 WR3095 wound only 
mutant 1  mutant 8  mutant 5  mutant 4  deletion 
B)  mutant 6  mutant 3  mutant 2  mutant 7 
positive  controls  negative controls 
WR5100  A348  WR5000 WR3095 wound only 
Figure 3.16 133 
Tomato Inoculations
 
Tomato stems were wounded and inoculated with wild-type  or 
mutant A. tumefaciens strains and scored for tumors after four 
weeks.  The stems were also infected with the negative control 
strains WR5000 and WR3095 for comparison. WR5000, the virE2 
null strain, formed a few tiny tumors on the tomato  stems (Figure 
3.17).  WR5000 transformed with insertions 2, 5, and 6  were also 
nearly avirulent on tomato stems; their phenotypes  were identical to 
WR5000.  Insertion 4 formed tumors that were intermediate in  size 
between tumors formed by the wild-type strains and  tumors formed 
by WR5000.  Insertions 1, 3, 7, 8, and the deletion were virulent and 
formed tumors that were similar in number and size to wild-type. 
The tumorigenesis studies are summarized in Table 3.2. 134 
Figure 3.17. Tomato stems infected with  A.  tumefaciens 
mutants.  Tomato stems were wounded and infected  with wild-type
or mutant A. tumefaciens strains.  Positive control strains included 
A348, with wild-type virE2  on the Ti plasmid and WR5100, 
containing a deletion of virE2 from the Ti plasmid  and a broad-host 
range plasmid containing a wild-type copy of  virE2.  Negative 
controls included WR5000, containing  a deletion of virE2 on the Ti 
plasmid and WR3095, which has both of the  right-border repeats of 
the T-DNA regions deleted from the Ti plasmid. 
A) Left-A348 (top), WR5100 (center), wound-only  (bottom)
Right- WR5000 (top), WR3095 (bottom) 
B) mutant 7 (WR5107), mutant 1 (WR5101),  mutant 3 (WR5103) 
D) mutant 6 (WR5106), mutant 3 (WR5103), mutant 2 (WR5102) 
E) mutant 5 (WR5105), mutant 4 (WR5104), deletion  (WR5110) 135 
A) 
A348 
WR5000 
WR5100 
WR3095 
wound only 
B) 
mut. 7  mut. 6  mut. 5 
mut. 1  mut. 3  mut. 4 
mut. 8  mut. 2  del. 
Figure  3.17
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Table 3.2.  Virulence of strains with mutations in virE2 on potato 
discs, carrot, K. daigremontiana and tomato. 
virE2 
allele 
potato  carrot  K. daigremontiana  tomato 
wild­ 1 00  wild-type  wild-type  wild-type 
type 
ins.1  4.5  variable:  wild-type 
small to  wild-type 
ins. 2  0.24 
ins. 3  47  wild-type  wild-type  wild-type 
ins. 4  0.60  reduced  intermed. 
size 
ins. 5  0.48 
ins. 6  1.6 
ins. 7  42  +I- wild-type  wild-type 
ins. 8  37  +1­ wild-type  wild-type 
del. 1  66  wild-type  wild-type  wild-type 137 
Single-stranded DNA Binding 
To locate domains important for DNA binding,  we assessed the 
ssDNA binding activity of each mutant. E. coli extracts  were 
prepared containing wild-type and mutant VirE2 proteins (see 
Protein methods section 2.5).  These extracts were used to  assay for 
ssDNA binding (see DNA methods section 2.3).  The single-stranded 
DNA (ssDNA) binding data are shown in Figure 3.18. The  signals were 
quantitated using a Molecular Dynamics phosphorimager with 
ImageQuant software. 
To determine the percentage of probe bound, the signal  that 
shifted to the top of the gel due to binding to VirE2  was divided by 
the total signal in each lane; this took into account small 
differences in the amount of probe loaded in each lane.  To test for 
ssDNA binding by other proteins in the extract, labeled ssDNA  was 
incubated with extract from a strain containing only pTrc99A;  the 
amount of protein added, estimated by the Bradford dye-binding 
method (Bio-Rad) equaled the total protein in incubations containing 
the maximum amount of VirE2.  These control extracts shifted only 3 
to 6 percent of the probe to the top of the gel, indicating that the 
contribution by other SSB proteins was minimal.  The percentage of 138 
Figure 3.18.  Single-stranded DNA binding assays of protein
extracts from E. coli strains overexpressing  mutant forms 
of VirE2.  a) wild-type; b) mutant 1; c) mutant 2;  a lane with 21 ng
of mutant 1, which binds similarly to wild-type,  was also included 
as a positive control  d) mutant 3; e) mutant 4; f) deletion; 
e) mutants 5 and 6; a lane with 21 ng of Deletion 1, which  binds 
similarly to wild-type, was also included as  a positive control. 
Lane 1. 22 ng mutant 5 VirE2 
Lane 2. Protein extract from E. coli containing plasmid  pTrc99A
(vector control) 
Lane 3.  22 ng mutant 6 VirE2 
Lane 4.  Protein extract from E. coli containing plasmid pTrc99A 
(vector control) 
Lane 5. 21 ng Deletion 1 139 
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probe shifted by the VirE2 protein in the E.  coli cell extracts as
 
determined using the phosphorimager, is plotted  versus the amount 
VirE2 protein in each extract in Figure 3.19. 
Insertion mutant 2 showed decreased  cooperative binding; less 
of the probe is shifted to the bound region of  the gel compared to 
wild-type VirE2.  Mutant 3 showed increased cooperative  binding, 
visualized as a more rapid transition from  unbound to fully bound 
probe when compared to wild-type VirE2. Mutants one and four and 
the deletion mutant showed binding similar  to wild-type VirE2. 
Mutants 5 and 6 did not bind ssDNA; neither shifted any of the probe 
to the top of the gel. 
Accumulation of VirE2 in A.  tumefaciens 
The accumulation of mutant VirE2 proteins  produced in A. 
tumefaciens  was determined by immunoblot analysis of A. 
tumefaciens cell extracts and compared with the  accumulation of 
wild-type VirE2 protein (Figure 3.20).  Mutant proteins 1, 2, 5 and 6 
did not accumulate VirE2 to wild-type levels in A.  tumefaciens. 
Insertion mutants 3, 4, 7, 8 and the deletion  mutant accumulated 
VirE2 to levels similar to wild-type. 142 
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Figure 3.19.  Single-stranded DNA binding affinities of
wild-type and mutant VirE2 proteins. wild-type  mutant 1 -0­
deletion  mutant 2  mutant 3 4.- mutant 4 o- mutant 5-A- mutant 611. 
Mutant 2 shows decreased cooperative DNA  binding compared to
wild-type.  Mutant 3 shows increased cooperative DNA  binding
compared to wild-type. 143 
Figure 3.20.  Immunoblots of protein extracts from  A. 
tumefaciens strains with mutations in virE2,  without(-)
and with(+) vir gene induction by acetosyringone.  a) wild-
type (WR5100), mutant 1 (WR5101), mutant 2 (WR5102),  mutant 3 
(WR5103), mutant 4 (WR5104); b) wild-type (WR5100),  mutant 5 
(WR5105), mutant 6 (WR5106), mutant 7 (WR5107),  mutant 8 
(WR5108); c) wild-type (WR5100), deletion 1 (WR5110). 
a.s. = acetosyringone 144 
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Summary of Mutant Phenotypes 
Abolition of Single-stranded DNA Binding and
 
Virulence
 
Insertion mutations 5 and 6, which lie in the C-terminal  half 
of VirE2 (Figure 3.1), eliminated single-stranded DNA  binding 
(Figures 3.18 and 3.19) and severely reduced tumorigenesis  on potato 
discs (Table 3.1, Figures 3.13 and 3.14).  Both mutants also severely 
reduced virulence on K. daigremontiana leaves (Figure 3.16),  tomato 
(Figure 3.17), and carrot (Figure 3.15).  These insertions also prevent 
the accumulation of VirE2 to wild-type levels in A. tumefaciens 
(Figure 3.20). 
Changes in  Cooperativity 
Insertions 2 and 3, located in the N-terminal half of VirE2 
(Figure 3.1), influenced the cooperative binding of VirE2 to ssDNA. 
Insertion 2 decreased the ability of VirE2 to bind cooperatively; less 
of the probe was shifted to the bound region of the gel when 
compared to wild-type VirE2 (Figure 3.18). 146 
This decreased the sigmoidal nature of the ssDNA binding 
curve (Figure 3.19).  Insertion 2 also reduced VirE2 accumulation in 
A. tumefaciens (Figure 3.20) and nearly abolished  tumorigenesis on 
all plants tested.  Therefore, the severe decrease in tumorigenesis 
may be attributed to the instability of VirE2 with this insertion in 
A. tumefaciens.  Insertion 3 increased cooperative ssDNA binding, 
causing an extremely rapid transition from unbound probe  to fully-
shifted probe (Figures 3.18 and 3.19).  This mutation decreased 
tumorigenesis on potato discs by half compared to wild-type  VirE2 
(Table 3.1, Figures 3.13 and 3.14).  A students t-test (Langley 1971) 
indicated that this difference was significant (P<0.01).  However, 
this strain appeared fully virulent on K. daigremontiana  (Figure 
3.16), tomato (Figure 3.17), and carrot (Figure 3.15).  Insertion 3 did 
not decrease the accumulation of VirE2 protein in A. tumefaciens 
cells (Figure 3.20). 
Wild-type Single-stranded DNA Binding and Virulence 
A deletion of ten amino acids from the N-terminus of VirE2 
(Figure 3.1) had little effect on its ability to bind ssDNA (Figures 
3.18 and 3.19) or on tumorigenesis on potato discs (Table 3.1, 147 
Figures 3.13 and 3.14).  This mutant was fully virulent on K. 
daigremontiana (Figure 3.16), carrot (Figure 3.15), and tomato 
(Figure 3.17); this mutant VirE2 protein  was stable in A. 
tumefaciens (Figure 3.20). 
Wild-type Single-stranded DNA Binding  and Decreased 
Virulence 
1 Insertion  (in the N-terminal half of VirE2) and insertion  4 (in 
the central region of VirE2) significantly reduced  tumorigenesis 
without affecting its ability to bind ssDNA (Figures 3.18  and 3.19). 
The virulence of insertion mutant 1  was severely decreased on 
potato discs (4.4% of wild-type, Table 3.1, Figure 3.14) and  carrot 
(Figure 3.15).  Insertion  1 was tumorigenic on tomato (Figure 3.17) 
and had variable virulence on K. daigremontiana (Figure  3.16), 
forming small- to normal-sized tumors.  Insertion  decreased the 1 
accumulation of VirE2 in A. tumefaciens cells (Figure 3.20),  which 
probably accounts for the reduction in tumorigenesis caused  by this 
mutation.  Insertion mutant 4 decreased virulence  on potato discs to 
less than 4) and also severely reduced virulence on carrot slices 
(Figure 3.15).  Mutant 4 formed fewer tumors on tomato (Figure 3.17) 148 
and smaller tumors on K. daigremontiana (Figure 3.16)  compared to 
wild-type A. tumefaciens, and this mutant VirE2 protein  was stable 
in A. tumefaciens (Figure 3.20), indicating that this  mutation 
affects another property of VirE2 other than ssDNA  binding or VirE2 
accumulation in A. tumefaciens. 
C-terminal  Insertions 
Insertions 7 and 8 destabilized VirE2 in E. coli, which 
prevented an accurate estimate of their binding to ssDNA.  Both 
mutations lie near the C-terminus of VirE2 (Figure 3.1),  and each 
slightly reduced tumorigenesis, to about 40% of wild-type,  on potato 
discs (Table 3.1, Figures 3.13 and 3.14), and these mutations  also 
reduced virulence on carrot (Figure 3.15).  Both strains exhibited full 
virulence on K. daigremontiana (Figure 3.16) and tomato (Figure 
3.17).  VirE2 protein with either insertion accumulated to wild-type 
levels in A. tumefaciens  cells (Figure 3.20). 149 
Summary 
A genetic map of the mutations in virE2 with  a summary of the 
results tabulated beneath each mutation is  presented in Figure 3.21. 
Insertions 5 and 6  did not bind to ssDNA.  Insertions 2 and 3 
influenced cooperative binding to ssDNA.  Insertions 1, 4 and the 
deletion mutant all bound to ssDNA similarly  to wild-type VirE2 
protein.  However, insertions 1 and 4 decreased virulence on the host 
plants.  Insertion 1 destabilized VirE2 in A. tumefaciens,  and 
probably as a result, its virulence is decreased. 150 
Figure 3.21.  Map of mutations in virE2 with  summary of
results.  NLS=nuclear localization signal, NLS 1= 205-KLR PED RYV QTE RyG RR -226 NLS 2= 273-KRR YGG ETE IKL KSK-287 The  basic amino 
acids in the nuclear localization sequences  are underlined.  A =the 
deletion of residues 56-65 (SSSLY SGSEH) from  virE2 ;  L=leucine; 
E=glutamic acid; S=serine; R=arginine; D=aspartic acid;  A=alanine; 
P=proline; Y=tyrosine; V=valine; Q=glutamine; T=threonine; 
G=glycine; K=lysine.  Insertion 1=LE;  Insertion 2=SS;  Insertion 
3=SR;  Insertion 4=LE;  Insertion 5=SS;  Insertion 6=the replacement 
of residue 472, a tyrosine by a serine and the insertion of an 
arginine and aspartic acid after residue 472;  Insertion 7=RA; 
Insertion 8=SR.  Binding:  ng of wild-type or mutant VirE2 needed to 
bind 50% of the ssDNA probe fully.  ND=not determined.  Virulence: 
percentage of wild-type virulence on potato discs.  Stability: 
accumulation of wild-type or mutant VirE2 in acetosyringone­
induced  A. tumefaciens  cells. 151 
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CHAPTER 4.  DISCUSSION
 
Introduction to the Chou and Fasman Method of Secondary 
Structure  Prediction 
One goal of this research was to identify domains required for 
ssDNNA binding and cooperativity using insertional mutagenesis. 
The changes in VirE2 protein structure as a result of this 
mutagenesis were predicted using the method of Chou and Fasman 
(1978).  The prediction of protein secondary and tertiary structure 
can be determined only by high resolution X-ray crystallography or 
nuclear magnetic resonance (NMR). Over twenty methods have been 
proposed to predict secondary structure based on the assumption 
that the amino acid sequence of a short region determines its local 
structure (Branden and Tooze 1991). 
An accepted method of predicting secondary structure is that 
of Chou and Fasman (Branden and Tooze 1991).  Their research 
involved the statistical analysis of 15 proteins with known X-ray 
structure, establishing alpha helix and beta sheet conformation 
potentials for all 20 amino acids  (Chou and Fasman 1973).  Short 153 
regular turns were also predicted.  The preferences for different 
amino acids at the first, second, third and fourth  position of a bend 
are also taken into account (Branden and Tooze 1991). 
In a Chou-Fasman prediction the amino acid  sequence is first 
analyzed for the formation of alpha helices and  beta sheets which 
are extended at both ends until a residue occurs with a high 
probability of turns or a low probability of both  alpha helix and beta 
strand formation (Branden and Tooze 1991). 
Often protein regions contain residues with  a high probability 
of both alpha helix and beta strand formation,  therefore the 
following rules are useful (Branden and Tooze  1991).  One, alpha 
helices usually contain a greater number of residues  than beta 
strands and there is almost always  a turn between regions of alpha 
helix and beta sheet.  Two, there is also a high probability that when 
there are one or two alpha helices among many beta strands that 
they all should be beta strands. 
The Chou and Fasman method had an overall accuracy of 50% 
based upon the analysis of a large number of X-ray structures 
consisting of over 10,000 residues (Branden and Tooze 1991).  Many 
of the errors occurred at the ends of alpha helices and beta sheets, 154 
whereas their central regions were correctly  predicted, and some 
errors occurred because of the difficulty in differentiating  between 
helix and strand. 
The secondary structure predictions  were generated by the 
program, Mac Vector, using the Chou-Fasman method of secondary 
structure  prediction. 
Insertions 5 and 6 Identified a Single-stranded  DNA 
Binding Domain 
VirE2 has two nuclear localization  sequences (NLSs) (Figure 
4.1, Citovsky et al. 1992), and conversion of two lysine residues to 
glycine in the C-terminal NLS decreases the efficiency  of nuclear 
localization and abolishes ssDNA binding (Citovsky  et al. 1994). 
Insertions 5 and 6, in the C-terminal half of VirE2,  also eliminated 
ssDNA binding. 
This suggests that the ssDNA binding domain  may extend from 
the lysine residues of this NLS (residues 285 and 287) through 
insertion 5 (after residue 378) and to insertion 6 (after  residue 471, 
Figure 4.1).  The secondary structure of this DNA binding region 155 
Figure 4.1. Secondary Structure Prediction  of VirE2.  VirE2 
is shown schematically above the secondary  structure prediction. 
NLS=nuclear localization signal,  NLS 1= 208-KLR PED RYV OTE MG 
RR-226 NLS 2= 273-KRR YGG ETE IKL KSK-287 The basic amino acids in 
the nuclear localization sequences  are underlined.  A =the deletion of 
residues 56-65 (SSSLY SGSEH) from virE2 Numbers  1-8 indicate 
positions of linker insertions. The boxes indicate:  top - alpha helix, 
middle - beta strand, bottom  - turn (by the method of Chou and 
Fasman 1978). coop.  coop. 
N LS 1  N LS 2 
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(from residues 285 through 471) is predicted to be primarily alpha 
helix and turn (Figure 4.1).  Insertion 5 inserts two serines which 
slightly extends a predicted alpha helix (Figure 4.2).  Presumably, 
this change in secondary structure brought about  by the insertion 
most likely perturbs a region of VirE2 critical for DNA  binding. 
Insertion 6 similarly results in localized changes  of predicted 
secondary structure (Figure 4.3).  This insertion adds arginine and 
aspartic acid after residue 472, which is changed from  a tyrosine to 
a serine.  Thus, this linker insertion adds two charged amino  acids, 
one basic and one acidic.  Tyrosine and serine are both polar amino 
acids, although tyrosine is also an aromatic residue and  therefore 
may interact with the DNA bases during binding (Prasad and Chiu 
1987). 
Insertion 6 also extends a putative region of turn that  begins 
near amino acid 460 and continues for about 7 amino acids, 
eliminating a region of beta strand and extending  a region of turn. 
This change may also occur in, or near the ssDNA binding domain, 
since this mutation completely eliminates binding to ssDNA. 
Conversion of the two lysine residues to glycines (in the NLS, 
Citovsky et al. 1994) also results in only localized changes  in 158 
Figure 4.2.  Secondary Structure Prediction of VirE2
Mutated by Linker Insertion 5.  A) wild-type VirE2, B)  insertion 
5, two serines were inserted after residue.  The boxes indicate:  top 
- alpha helix, middle - beta strand, bottom - turn. 360  370  380  390  400  410  420  430  440
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Figure 4.3. Secondary Structure Prediction  of VirE2 
Mutated by Linker Insertion 6. A) wild-type VirE2,  B) insertion
6, an arginine and an aspartic acid  were inserted after residue 472, 
residue 472 was also changed from  a tyrosine to a serine. The boxes 
indicate:  top - alpha helix, middle  beta strand, bottom  - turn. 410  420
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predicted secondary structure (Figure 4.4).  Therefore, these three 
mutations are likely to define the ssDNA binding domains  of VirE2. 
Insertions 2 and 3 Result in Changes in Cooperative  DNA 
Binding 
Insertion 2 decreased the stability of VirE2 in A.  tumefaciens, 
almost abolished tumorigenesis, and decreased cooperative  DNA 
binding to ssDNA.  Because this mutation decreased the stability of 
VirE2 in A. tumefaciens, the influence of decreased  cooperativity on 
tumorigenesis could not be determined.  To determine whether 
tumorigenesis depends upon cooperative ssDNA binding by VirE2, a 
mutation that specifically eliminates cooperativity without 
destabilizing the protein or affecting NLS activity should  be 
constructed and analyzed. 
In this mutant VirE2, two serine residues  were inserted after 
residue 94, extending  a putative turn region that begins near 
residue 80 (Figure 4.5).  It  is unlikely that this localized change 
disrupts the overall protein conformation.  However, the mutant 
protein was destabilized in A. tumefaciens, possibly by increased 
susceptibility to proteases, or by decreased protein-protein 163 
Figure 4.4.  Secondary Structure Prediction of VirE2 
Mutated by Changing Residues 285 and 287 from  Lysines to
Glycines. 
A) Wild-type VirE2, B) VirE2 with residues 285  and 287 changed 
from leucines to glycines (Citovsky et al. 1994),  these residues are 
part of one of the nuclear localization signals. The boxes  indicate: 
top  alpha helix, middle  - beta strand, bottom - turn. a 
Po 
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Figure 4.5.  Secondary Structure Prediction of VirE2
Mutated by Linker Insertion 2.  A) wild-type, B) insertion 2,  two 
serines were inserted after residue 94.  The boxes indicate:  top ­
alpha helix, middle  - beta strand, bottom - turn. 70
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interactions, either with itself or with other proteins  necessary for 
the accumulation of VirE2 in A. tumefaciens. 
Insertion 3 (after residue 213) did not destabilize  VirE2 in A. 
tumefaciens, and it affected tumorigenesis only  slightly.  Insertion 
3 adds a serine and an arginine after residue 213 which increased 
the cooperativity of ssDNA binding, in contrast to another mutation 
in this region that reduced cooperativity (Citovsky  et al. 1994).  The 
new arginine residue could interact ionically with negatively 
charged oxygens on the DNA backbone, increasing the  affinity of this 
mutant protein for ssDNA (Prasad and Chiu 1978).  This insertion 
also slightly enlarges a region of putative random coil,  as no helix, 
sheet or turn regions are predicted in this  area and the secondary 
structure predictions outside this immediate  area are unchanged 
(Figure 4.6). Therefore, the addition of a charged amino acid, rather 
than a structural change, probably results in the increased 
cooperativity of this mutant. 168 
Figure 4.6. Secondary Structure Prediction of  VirE2 
Mutated by Linker Insertion 3. A) wild-type VirE2,  B) insertion 
3, a serine and an arginine were inserted after residue 213. The 
boxes indicate:  top - alpha helix, middle  - beta strand, bottom ­
turn. 190  200  210  220  230  240  250  260  270  280  290  300  310 
r  *  *  *  *  * 
ITGTEI FIGTDKNIKLDRNYKLRPED RYVQTERYGR REIQKRYQHE LQAGSLLFDI MIKTPKNDIHFVYRFAGDNY ANKQFSEFEH  TVKRRYGGET  EIKLKSKSGI MHDSKYLESWERGSADIRFA.EFVGE 
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The VirE2 Deletion Resulted  in  Wild-type Single-stranded
DNA Binding and Virulence 
The serine-rich region (SSSLYSGS) deleted from  VirE2 shows 
sequence similarity to another non-specific single-stranded DNA 
binding protein encoded by gene 32 of bacteriophage T4 (gp32) 
(SSSGSSSS) (Hurley et al. 1993; Krassa et al. 1991).  This region of 
gp32 interacts with other proteins during T4 DNA  replication (Hurley 
et al. 1993; Krassa et al. 1991).  Interestingly, deletion of this 
region from VirE2 had no effect on tumorigenesis  or its ssDNA 
binding ability; this serine-rich region is apparently  unimportant for 
VirE2 function.  This deletion of residues 55 to 65 shortened  a 
predicted turn region that begins near residue 45,  but it did not 
change the predicted secondary structure outside this  region (Figure 
4.7).  This turn is not in a functionally important region  of VirE2 
because its length is unimportant for VirE2 function. 171 
Figure 4.7.  Secondary Structure Prediction of VirE2
Mutated by a Deletion of Residues 55-65.  A) wild-type VirE2, 
B) deletion of residues 55-65. The boxes indicate:  top - alpha helix, 
middle - beta strand, bottom  - turn. 10 20  30  40  50  60 70
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Insertions  1  and  4:  Wild-type Single-stranded DNA 
Binding and Reduced Tumorigenesis 
Two linker insertions (1 and 4) reduced tumorigenesis without 
affecting ssDNA binding.  Mutations that cause this phenotype may 
have influenced a function of VirE2 (other than ssDNA binding) that 
is important for T-DNA transmission or, alternatively, cause a 
destabilization of VirE2 in A.  tumefaciens. 
Immunoblots showed that insertion  reduced tumorigenesis by 1 
preventing normal accumulation of VirE2 in A. tumefaciens. 
Insertion 1 adds leucine and glutamic acid after residue 10 of VirE2. 
Leucine has a hydrophobic side chain while the side chain of 
glutamic acid is negatively charged.  Both of these amino acids are 
strong helix formers according to the Chou and Fasman method of 
secondary structure prediction (1978).  Consequently, insertion  1  is 
predicted to add an alpha helix of about seven amino acids in length 
to a region of turns (Figure 4.8).  Although this change does not 
affect the ssDNA binding ability of VirE2, and would not be predicted 
to (because it  is located near the N-terminus), it does decrease the 174 
Figure 4.8. Secondary Structure Prediction  of VirE2 
Mutated by Linker Insertion  1. A) wild-type VirE2, B) insertion
1, a leucine and a glutamic acid were inserted after residue 10.  The 
boxes indicate:  top - alpha helix, middle  - beta strand, bottom ­
turn. 10
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stability in A. tumefaciens.  The decreased stability of this VirE2 
mutation leads to reduced virulence. 
In contrast, insertion 4 appears to alter an important property 
of VirE2 other than ssDNA binding or protein stability.  As with 
insertion 1, insertion 4 also adds leucine and glutamic acid residues, 
again resulting in the predicted formation of an alpha helix of 
roughly 7 amino acids in length (Figure 4.9).  This insertion is 
located between the 2 NLS regions of wild-type VirE2.  Because 
insertion 4 VirE2 and wild-type VirE2 bind ssDNA similarly (Figures 
3.13 and 3.14), this insertion probably does not result in large 
changes in tertiary structure.  Insertion 4 may therefore define a 
domain required for T-DNA integration inside the plant cell, or VirE2 
export from the A. tumefaciens cell. 177 
Figure 4.9. Secondary Structure Prediction of VirE2 
Mutated by Linker Insertion 4. A) wild-type VirE2, B) insertion 
4, a leucine and a glutamic acid were inserted after residue 256. 
The boxes indicate:  top - alpha helix, middle  - beta strand, bottom ­
turn. 210  220  230  240  250  260  270  280  290  300
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Secondary Structure Comparison of VirE2 with RecA,  SSB 
and gp32 
The secondary structure of VirE2  was compared with those of 
three other proteins, all of which have been shown to bind 
cooperatively to ssDNA in a non-specific fashion (Figure 4.10).  The 
proteins chosen were RecA, the single-stranded DNA binding  protein 
(SSB) from E. coli, and gp32 from bacteriophage T4. SSB  and gp32 
function primarily by melting out secondary structure in ssDNA  to 
facilitate DNA replication and repair (Chase and Williams  1986). 
Both proteins also protect exposed ssDNA from nucleases.  RecA, on 
the other hand, has a more active role in DNA recombination and 
repair (Cox and Lehman 1987; Egelman 1993; Roca and Cox 1990). 
RecA promotes a strand exchange reaction between single-stranded 
and double-stranded DNA, hydrolyzes ATP and facilitates the 
cleavage of the LexA repressor, UmuD, and the X repressor (Cox and 
Lehman 1987; Egelman 1993; Roca and Cox 1990). The crystal 
structures of both RecA and gp32 have been reported (Egelman and 
Stasiak 1986; Shamoo et al. 1995). 180 
Figure 4.10.  Secondary Structure Predictions of VirE2, 
RecA, gp32 and SSB. A) VirE2, B) RecA, C) SSB, D) gp32. The 
boxes indicate:  top - alpha helix, middle  - beta strand, bottom ­
turn. 100  200  300  400  500
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The DNA Binding and Strand-exchange  Domain of RecA: 
Similarities  to  VirE2 
The crystal structure of RecA without  DNA suggests that the 
paired DNA strands reside in the center of  a protein helix (Story et 
al. 1992). Two disordered loops line this helix and studies of RecA 
binding implicate one of these loops in DNA  binding (Egelman and 
Stasiak 1986; Story et al. 1993; Mayerboeuf  et al. 1995).  This DNA 
binding loop includes a central phenylalanine  that contacts the DNA. 
A 20 amino acid peptide, corresponding  to residues 193-212, lies 
within this binding loop and can bind  cooperatively to ssDNA 
(Gardner et al. 1995).  This 20 amino acid peptide is also able to 
promote homologous DNA pairing and strand  exchange (Voloshin et al. 
1996); ten to twenty percent as  many joint molecules are formed 
compared to full-length (353 amino acids) RecA.  In this 20 amino 
acid peptide, a central phenylalanine at position  203 is highly 
conserved among both prokaryotic and eukaryotic  RecA homologs 
(Story et al. 1993).  If tryptophan replaces this phenylalanine the 
cooperativity of ssDNA binding by this peptide is  increased and this 
altered peptide is still able to promote strand  exchange (Voloshin et 
al. 1996).  Other substitutions for this phenylalanine  decrease 183 
cooperativity or eliminate ssDNA binding and  are not able to form 
joint molecules.  In addition to the central phenylalanine  residue, 
the two amino acids at either end of this  region are highly 
conserved. VirE2 has no sequence homology to the peptide or to the 
highly conserved amino acids. 
The 20 amino acid RecA peptide undergoes  a change from 
random coil to beta strand and turn upon binding ssDNA (Voloshin et 
al. 1996).  Chou-Fasman predicts this region (residues from  193­
212), to form both beta stand and turn.  Two regions in VirE2, 
beginning at amino acids 190 and 250  are most similar in predicted 
secondary structure to this region in RecA, although  both the strand 
and turn regions in VirE2 are considerably  shorter.  Insertion 4 
(after residue 260), which does not affect ssDNA  binding but may be 
required for T-DNA integration lies close to  one of these regions. 
Because VirE2 can mediate genetic recombination,  it  is tempting to 
speculate that one of these regions in VirE2 is needed for T-DNA 
integration.  Because there is  little secondary structural and 
sequence similarity between VirE2 and this region of RecA, it  is 
unlikely that VirE2 mediates strand exchange in the  same manner as 
RecA. 184 
The DNA Binding Domain of gp32: Similarities  to
 
VirE2 
The crystal structure of gp32 complexed to ssDNA  has recently 
been determined (Shamoo et al. 1995).  This crystal structure 
confirms the importance of electrostatic interactions  between the 
lysine and arginine residues of gp32 and the phosphate  oxygens of 
the DNA backbone (Prasad and Chiu, 1987).  However, intercalation of 
the aromatic side chains into the DNA does not occur as predicted 
(Prasad and Chiu, 1987).  Instead the bases lie near pockets of 
hydrophobic residues that surround a DNA binding  groove. The groove 
is narrow, allowing gp32 to differentiate between ssDNA  and dsDNA. 
The DNA binding region of gp32 (residues 21-254)  is 
predominantly sheet and turn (Shamoo et al. 1995), agreeing with 
the Chou-Fasman secondary structure prediction (Figure 4.10). 
However, the putative ssDNA binding domain in VirE2 (residues 285­
472) is predicted to be  predominantly alpha-helix (Figure 4.10). 
Therefore, VirE2 may not bind to single-stranded DNA in the same 
way gp32 binds. 
In gp32, the serine-rich region (residues 281-288) which 
interacts with other T4 DNA replication proteins, is in  a region of
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beta turn (Figure 4.10).  The corresponding region in VirE2 (residues 
55-65), is also in a region of turn, although it  is not surrounded by 
acidic residues as it  is in gp32.  Since deletion of these residues 
from VirE2 had little effect on either ssDNA binding or 
tumorigenesis, this region is not critical for those functions of 
VirE2. 
The DNA Binding Domain of SSB:  Similarities to VirE2 
SSB differs from other ssDNA binding proteins because 
depending on the ratio of SSB protein to ssDNA and the salt 
concentration, SSB tetramers can bind to ssDNA in several modes 
(Lohman and Overman 1985).  In one mode, the ssDNA wraps around 
one or two SSB tetramers and the DNA/SSB complex has a beaded 
appearance.  At higher protein concentrations, the DNA does not wrap 
around the SSB protein and a smooth filament is formed instead.  The 
amino terminal end (residues 1-105) binds to ssDNA,  as well as to 
the full length protein.  This domain is predicted to be beta strand 
and turn like the ssDNA binding domain of gp32 and therefore, 
differs from VirE2.  The carboxy terminus of SSB and gp32 contains 
an acidic region, suggesting that this SSB domain might interact
 186 
with other replication proteins as has been demonstrated  for gp32 
(Chase and Williams 1986). 
Cooperative Binding of VirE2, RecA, gp32 and SSB 
VirE2, gp32, RecA, and SSB all exhibit cooperative  binding to 
ssDNA, and studies with gp32 provide the most information.  In 
dilute solution gp32 exists as a monomer, but at higher 
concentration it undergoes self-association (Alberts and Frey  1970). 
Removal of the first 9 residues from gp32 (Met-Phe-Lys-Arg-Lys-
Ser-Thr-Ala-Glu) results in a protein that binds non-cooperatively 
and it fails to aggregate in solution (Hosoda et al. 1980).  Since 
removal of these amino acids eliminates both cooperative  DNA 
binding and self-association in solution, both  processes are thought 
to be related (Chase and Williams 1986).  Residues 3-7 in gp32 are 
identical to residues 110-114, and both regions have been 
designated as LAST (Lys- Arg- Lys-Ser-Thr) motifs (Casas-Finet  et 
al. 1992). The LAST motif has several basic amino acids 
(underlined). A model has been proposed to explain cooperative 
ssDNA binding in gp32 (Casas-Finet et al. 1992). When gp32 is not 
bound to ssDNA, the central LAST motif interacts with  a negatively 187 
charged region of the protein.  This negatively charged region is 
displaced when gp32 binds ssDNA freeing  this region to interact 
with the N-terminal LAST motif in  an adjoining gp32 molecule, and 
thus nucleate cooperative binding.  The N-terminal LAST motif is in 
an alpha helical region of predicted secondary structure  (Figure 
4.10). 
VirE2 has no similar LAST motif, although  VirE2 bearing either 
insertions 2 or 3 caused a change in cooperative DNA binding. 
However, only insertion 3 is surrounded by basic  amino acids, 
because it interrupts a NLS.  Therefore, VirE2 cooperativity probably 
does not fit the model proposed for gp32.  VirE2 does form a 
tetramer in solution (Das 1988), suggesting that  protein-protein 
interactions are responsible for the cooperative binding  of VirE2 to 
ssDNA.  It would be of interest to purify VirE2 bearing  insertions 2 
or 3 and determine whether the mutant VirE2 proteins could form  a 
tetramer.  Insertion 2 may not form a tetramer in solution and may 
instead exist predominantly as a monomer or dimer since this 
insertion decreased cooperativity.  Insertion 3, on the other hand, 
may form tetramers or larger complexes of VirE2 protein since this 
insertion resulted in increased cooperativity.  Insertion 2 decreased 188 
the cooperative binding of VirE2 and does not shift as much ssDNA to
 
the top of the gel as when wild-type VirE2 protein is  added (Figures 
3.14 and 3.15).  Several explanations for this observation  are 
possible.  If  protein-protein interactions are involved in cooperative 
binding to DNA, the conformational change  as a result of the 
insertion may result in weaker bond formation between  adjacent 
VirE2 monomers so that they are not packed  as closely together. 
Alternatively, this insertion might cause VirE2  monomers to 
aggregate, preventing additional monomers from binding.  Gp32 has a 
DNA binding groove and is postulated to slide along the ssDNA 
(Voloshin et al. 1996).  Therefore, if VirE2 binds to ssDNA similarly, 
this insertion may prevent VirE2 from easily sliding  on the ssDNA, 
resulting in fewer bound molecules. This change in VirE2  could also 
limit the ability of VirE2 to induce  a conformational change in the 
ssDNA that allows other VirE2 molecules to bind  more easily. 
As described for gp32 and VirE2, RecA forms  aggregates in 
solution due to a protein-protein interaction (Brenner et al. 1988). 
Removal of the N-terminal 33 amino acids of RecA decreases both 
aggregation and ssDNA binding (Mikawa et al. 1995). The authors 
speculate that the defective protein-protein interaction leads  to 189 
defective DNA binding.  This truncated protein interacts with full-
length RecA in a 1:1  ratio, presumably by an interaction between the 
N-terminal site in full-length RecA and an internal site in  the 
truncated protein (Mikawa et al. 1995).  In RecA, as in gp32, the N-
terminal cooperativity domain is  in a putative alpha helical region 
of secondary structure based on Chou-Fasman predictions (Figure 
4.10) and crystal structure analysis has shown residues 3-21  form 
an alpha helix (Story et al. 1992). 
Insertions 2 and 3 in VirE2 are both near putative alpha helical 
regions of secondary structure.  These regions may interact directly 
with charged regions in adjacent VirE2 monomers.  Point mutations 
of the charged residues in these adjacent alpha helical regions could 
pinpoint the residues involved in cooperative binding. The protein-
protein interactions between the mutant proteins should be 
characterized along with the ssDNA binding to more fully understand 
the nature of VirE2 cooperativity. 190 
Variability  in  Virulence Data 
Potato  Inoculations 
Quantitative virulence data were obtained using  potato discs. 
However, large standard deviations were observed  when these data 
were statistically analyzed.  For example, the average number of 
tumors per disc for the wild-type strain WR5100  was 8.3 +/-8.8.  In 
the potato inoculations, a potato disc with 8  or more tumors was 
sometimes located next to a disc with  no tumors.  However, tumor 
formation was consistent between potatoes:  a strain that was 
virulent or almost avirulent on one potato  was also virulent or 
almost avirulent on another potato.  The high standard deviation  was 
not decreased by compiling the results from the  potatoes which had 
a higher-than-average number of tumors when infected with 
WR5100, the wild-type strain.  Large standard deviations using this 
assay have been previously noted by others (Shurvinton et al. 1992). 
This suggests the variability in the data lies within  the individual 
potatoes.  Several reasons may explain this variability. 191 
Slices from the center of the potato where  the tissue is 
youngest, may be the most susceptible to infection.  Another 
possibility could be the variable length of time that  elapses between 
the cutting of a potato disc and inoculation.  The discs from a single 
potato are inoculated at the same time to minimize this  variability. 
However, a large potato may yield over 80 discs, and  therefore the 
time required to inoculate each disc can vary from 10 to 45 minutes. 
A combination of these possibilities could account  for the 
variability in the data. 
Host Range 
The A. tumefaciens strain WR5000, with  a virE2 deletion on 
the Ti plasmid, was avirulent on K. daigremontiana leaves, carrot 
slices and potato slices.  However, on tomato stems, a few very 
small tumors formed.  This indicates that VirE2 is critical for 
virulence on most plants, but that infection with  a strain containing 
deletion in virE2 can occur on very sensitive hosts.  This variability 
in sensitivity to infection was also noticed when different  hosts 
were infected by strains with insertions in virE2.  For example, 
insertion 4 exhibited less than 1% of wild-type tumors on potato 192 
discs and was almost avirulent on carrot slices.  Insertion 4 also 
formed smaller tumors on K. daigremontiana  leaves and fewer 
tumors on tomato stems compared to  a wild-type strain.  Insertion 1 
formed 4.4% of wild-type tumors  on potato discs and was also 
almost avirulent on carrot slices.  However, the tumors on K. 
daigremontiana leaves were smaller to wild-type in size, and it was 
virulent on tomato stems. 
Tomato stems are therefore the most sensitive  host tissues of 
the plants tested. We used cultivar Bonnie Best because of low 
natural disease resistance and high sensitivity  to A. tumefaciens 
infection (M. Canfield and L. Moore, personal  communication).  Potato 
discs and carrot slices are the least sensitive, and  K. 
daigremontiana leaves are intermediate in sensitivity. 
Differences in A. tumefaciens infection between  host plants 
has been noticed previously.  For example, removal of the NLS of 
VirD2 severely reduced virulence  on tobacco stems, but only slightly 
reduced virulence on potato discs (Shurvinton  et al. 1992). A. 
tumefaciens strains in nature have shown wide variability  in the 
range of plants they are able to infect (Knauf et al. 1982). The 
strains with a narrow host range have  a defective T-DNA cytokinin
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biosynthetic gene or changes in virA or virC and, therefore, are not 
as effective as other strains at infecting plants (Yanofsky  et al. 
1985).  These authors speculate that susceptible host  plants may 
require T-DNA integration into only  a few cells at the site of 
inoculation for tumors to appear, while less  susceptible plants 
require T-DNA integration into many cells.  Therefore, the frequency 
of T-DNA transfer is the critical host  range determinant. 
In virE2 mutants, the frequency of T-DNA transfer  is severely 
reduced.  For example, a virE2 deletion strain transferred  T-DNA into 
tobacco at a frequency 2,500X less than  a wild-type strain (Rossi et 
al. 1996).  This may explain the virulence phenotype  observed for 
WR5000, containing the virE2 deletion.  virE2 mutants can infect 
petunia leaf discs, a very sensitive host, at  a low frequency but not 
petunia stems (Horsch et al. 1986). When petunia leaf  discs were 
infected by a virE2 mutant, only one or two tumors  formed on one-
third to one-half of the discs, and often  no tumors were visible for 
the first two weeks after infection (Horsch et al. 1986).  On the 
other hand, mutations in virA, B, D and G completely  eliminate 
virulence on the petunia leaf discs (Horsch et al. 1986).  This is not 
surprising as these mutations would completely eliminate T-DNA 194 
export.  Therefore, the variability in virulence  on different host 
plants reported here when infected with the  virE2 insertion mutants 
or the virE2 deletion strain may be related to the  number of T-DNA 
molecules transferred. 
To summarize the results: the C-terminal  half of VirE2 
contains a domain critical for ssDNA binding  as insertions 5 and 6 
resulted in the loss of ssDNA binding ability.  Insertions 2 and 3, in 
the N-terminal half of VirE2, identified  cooperativity domains, 
because they either increased (insertion 3)  or decreased (insertion 
2)  cooperative binding to ssDNA.  Insertions 1 and 4 bind to ssDNA 
similarly to wild-type VirE2, nonetheless they  reduce virulence. 
Insertion 1  did not accumulate to wild-type levels in  A. 
tumefaciens, which accounts for its virulence  phenotype.  Insertions 
2, 5 and 6 also severely reduced the accumulation of VirE2 in A. 
tumefaciens and reduced tumorigenesis.  Insertion 4, in the central 
region of VirE2, did not affect the stability of VirE2  in A. 
tumefaciens.  This mutation could therefore define  another 
functional domain. 195 
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Preliminary  Data 
As mentioned in the introduction (see section entitled The Role 
of VirE2 in T-DNA Integration) VirE2 mediated genetic 
recombination in E. coli between 2 copies of the lacZ gene with non-
overlapping deletions.  No recombination occurred in the same E. coli 
background strain containing the vector alone or containing the virE 
operon with a deletion in the virEl gene. 
Because no colonies were observed in the E. coli strain with 
the deleted virEl gene, immunoblot analysis was performed to verify 
if the VirE2 protein was present.  Although VirE2 is stable in A. 
tumefuciens without VirE1 (Sundberg et al. 1996), VirE2 has been 
reported to be unstable in E. coli without VirE1 (McBride and Knauf 
1988).  An E. coli strain containing the virE operon with a frameshift 
mutation in the Bg/Il site of virE2 was also immunoblotted as well 
as a strain containing only the pTrc99A vector and a strain 
containing the entire virE operon. 221 
Twenty-ml cultures were grown overnight in  L-broth 
containing tetracycline, ampicillin and IPTG (2 mM).  The cells were 
harvested by centrifugation (9,500 RPM, SS34 rotor, 10 minutes) and 
resuspended on ice in 2 ml ice-cold buffer (10 mM Tris Hcl (pH 8.0), 
25 mM NaCI, 1 mM phenyl methyl sulfonyl fluoride (PMSF), 1 mM 
dithiothreitol).  The cells were lysed in a French press at 19,600 
pounds per square inch (PSI) and centrifuged (12,000 RPM, SS34 
rotor, 6 minutes).  The protein concentrations of the supernatants 
and the pellets dissolved in buffer were determined using the 
Bradford method dye-binding procedure (Bradford 1976, Biorad). 
The supernatant and pellet fractions were loaded (100 lig of 
the supernatant fractions and 10 gg of the pellet fractions) on a 10% 
SDS-polyacrylamide gel and immunoblotted (see Protein Methods in 
section 2.5).  The results are shown in Figure A1.1.  Only when both 
VirE1 and VirE2 are present, does a band corresponding in size to 
full length VirE2 appear.  This band does not appear when virEl is 
deleted or in the E coli strain containing the pTrc99A vector.  This 
VirE2 protein is insoluble as it only appears in the pellet fraction.  A 
band corresponding to truncated VirE2 is seen only in the strain 
containing the virE2 operon with a frameshift mutation in virE2. 222 
This truncated VirE2 protein is also insoluble as it appears only in 
the pellet fraction.  This experiment was repeated except the cells 
were induced with IPTG (2 mM) for 3 hours instead of overnight.  As 
expected, VirE2 was not present in the strain with the deletion in 
virEl.  However, the truncated VirE2 protein was also not observed 
indicating that this truncated protein may be unstable in E. coll. 223 
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Figure A1.1.  Immunoblot analysis of protein extracts from
E. coli  containing mutations in  virEl  and  virE2.
 
Lane 1  vector control supernatant (WR705)
 
Lane 2  El + E2 supernatant (WR724)
 
Lane 3  E2 only supernatant (WR797)
 
Lane 4  El + E2(frameshift) supernatant (WR798)
 
Lane 5  vector control pellet (WR705)
 
Lane 6  El + E2 pellet (WR724)
 
Lane 7  E2 only pellet (WR797)
 
Lane 8  El + E2(frameshift) pellet (WR798)
 